Gene Symbol | Gene ID | Gene Info |
---|---|---|
Smarcc1
|
ENSMUSG00000032481.10 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 1 |
Fosl1
|
ENSMUSG00000024912.5 | fos-like antigen 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr19_5448759_5448925 | Fosl1 | 921 | 0.232458 | 0.51 | 7.9e-05 | Click! |
chr19_5447521_5447969 | Fosl1 | 40 | 0.901960 | 0.15 | 2.7e-01 | Click! |
chr9_110206083_110206405 | Smarcc1 | 20512 | 0.128273 | -0.80 | 3.9e-13 | Click! |
chr9_110131564_110131784 | Smarcc1 | 306 | 0.859290 | 0.21 | 1.2e-01 | Click! |
chr9_110229224_110229375 | Smarcc1 | 5609 | 0.142045 | 0.12 | 3.7e-01 | Click! |
chr9_110228864_110229015 | Smarcc1 | 5969 | 0.140393 | 0.11 | 4.1e-01 | Click! |
chr9_110131800_110132613 | Smarcc1 | 169 | 0.932144 | 0.10 | 4.9e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr9_124257362_124257899 | 34.68 |
Gm39469 |
predicted gene, 39469 |
24509 |
0.16 |
chrX_170005299_170005846 | 23.67 |
Erdr1 |
erythroid differentiation regulator 1 |
4087 |
0.19 |
chr14_14351950_14353283 | 21.27 |
Il3ra |
interleukin 3 receptor, alpha chain |
2995 |
0.15 |
chr12_111353338_111354089 | 17.69 |
Cdc42bpb |
CDC42 binding protein kinase beta |
23906 |
0.13 |
chr14_47371718_47372034 | 17.49 |
Lgals3 |
lectin, galactose binding, soluble 3 |
1937 |
0.21 |
chr4_139179928_139180623 | 17.46 |
Gm16287 |
predicted gene 16287 |
380 |
0.82 |
chr3_104762286_104762711 | 16.66 |
Gm6485 |
predicted gene 6485 |
9333 |
0.09 |
chrY_90775323_90775967 | 16.50 |
Gm47283 |
predicted gene, 47283 |
9093 |
0.17 |
chr6_38342105_38342326 | 16.36 |
Zc3hav1 |
zinc finger CCCH type, antiviral 1 |
12058 |
0.13 |
chr13_119598970_119599326 | 16.34 |
Tmem267 |
transmembrane protein 267 |
7502 |
0.14 |
chr19_21106267_21106665 | 16.27 |
4930554I06Rik |
RIKEN cDNA 4930554I06 gene |
1756 |
0.44 |
chr11_60935403_60935625 | 16.26 |
Map2k3 |
mitogen-activated protein kinase kinase 3 |
3448 |
0.16 |
chr6_116286832_116287192 | 16.08 |
Zfand4 |
zinc finger, AN1-type domain 4 |
459 |
0.75 |
chr2_84938621_84938923 | 16.04 |
Slc43a3 |
solute carrier family 43, member 3 |
1882 |
0.24 |
chr10_77211333_77211524 | 15.37 |
Col18a1 |
collagen, type XVIII, alpha 1 |
44880 |
0.11 |
chr12_103863072_103863984 | 15.32 |
Serpina1a |
serine (or cysteine) peptidase inhibitor, clade A, member 1A |
23 |
0.95 |
chr10_121520996_121521267 | 15.20 |
Gm35696 |
predicted gene, 35696 |
10733 |
0.11 |
chrX_170004689_170005233 | 14.96 |
Erdr1 |
erythroid differentiation regulator 1 |
4698 |
0.18 |
chr1_184781740_184782518 | 14.74 |
Mtarc1 |
mitochondrial amidoxime reducing component 1 |
26724 |
0.12 |
chrX_170735840_170737140 | 14.57 |
Gm15069 |
predicted gene 15069 |
10717 |
0.28 |
chr13_56588245_56589118 | 14.47 |
2010203P06Rik |
RIKEN cDNA 2010203P06 gene |
6856 |
0.18 |
chr9_124256297_124256658 | 13.68 |
Gm39469 |
predicted gene, 39469 |
25662 |
0.16 |
chr13_119599987_119600237 | 13.61 |
Tmem267 |
transmembrane protein 267 |
6538 |
0.15 |
chr1_82831958_82832147 | 13.53 |
Gm22396 |
predicted gene, 22396 |
7394 |
0.1 |
chr1_86527639_86529135 | 13.48 |
Ptma |
prothymosin alpha |
1580 |
0.31 |
chr11_19924323_19926342 | 13.38 |
Spred2 |
sprouty-related EVH1 domain containing 2 |
890 |
0.71 |
chr7_103860925_103861255 | 13.35 |
Hbb-y |
hemoglobin Y, beta-like embryonic chain |
7874 |
0.06 |
chr5_14987708_14988443 | 13.32 |
Gm10354 |
predicted gene 10354 |
9140 |
0.21 |
chr14_76817069_76817629 | 13.21 |
Gm48968 |
predicted gene, 48968 |
15472 |
0.18 |
chr19_6969291_6970359 | 13.04 |
Plcb3 |
phospholipase C, beta 3 |
11 |
0.93 |
chr16_87306949_87307599 | 12.96 |
N6amt1 |
N-6 adenine-specific DNA methyltransferase 1 (putative) |
46911 |
0.15 |
chr3_97076076_97076280 | 12.94 |
4930573H18Rik |
RIKEN cDNA 4930573H18 gene |
16607 |
0.15 |
chr9_71663389_71664022 | 12.92 |
Cgnl1 |
cingulin-like 1 |
15355 |
0.21 |
chr6_67161663_67162061 | 12.90 |
A430010J10Rik |
RIKEN cDNA A430010J10 gene |
3062 |
0.22 |
chr5_15041810_15042547 | 12.83 |
Gm17019 |
predicted gene 17019 |
9180 |
0.25 |
chr12_103737920_103738559 | 12.80 |
Serpina1b |
serine (or cysteine) preptidase inhibitor, clade A, member 1B |
81 |
0.95 |
chr15_100599610_100600576 | 12.77 |
Pou6f1 |
POU domain, class 6, transcription factor 1 |
109 |
0.48 |
chr5_23850355_23851323 | 12.76 |
2700038G22Rik |
RIKEN cDNA 2700038G22 gene |
238 |
0.81 |
chr11_97435561_97436362 | 12.69 |
Arhgap23 |
Rho GTPase activating protein 23 |
324 |
0.87 |
chr9_108338578_108339700 | 12.57 |
Gpx1 |
glutathione peroxidase 1 |
85 |
0.89 |
chr2_170147589_170148059 | 12.55 |
Zfp217 |
zinc finger protein 217 |
279 |
0.95 |
chr5_144317459_144317816 | 12.50 |
Baiap2l1 |
BAI1-associated protein 2-like 1 |
28730 |
0.12 |
chr11_86593057_86593325 | 12.48 |
Vmp1 |
vacuole membrane protein 1 |
6197 |
0.16 |
chr5_137921592_137921941 | 12.46 |
Cyp3a13 |
cytochrome P450, family 3, subfamily a, polypeptide 13 |
147 |
0.9 |
chr9_8003315_8004975 | 12.45 |
Yap1 |
yes-associated protein 1 |
245 |
0.79 |
chr11_75651168_75652336 | 12.38 |
Myo1c |
myosin IC |
242 |
0.88 |
chr9_66988926_66989456 | 12.34 |
Gm24225 |
predicted gene, 24225 |
8006 |
0.16 |
chr6_72277117_72278124 | 12.20 |
Sftpb |
surfactant associated protein B |
26990 |
0.11 |
chr9_45042149_45042842 | 12.13 |
Mpzl2 |
myelin protein zero-like 2 |
70 |
0.94 |
chr14_32164269_32164594 | 11.91 |
Ncoa4 |
nuclear receptor coactivator 4 |
1158 |
0.33 |
chr13_53919976_53920436 | 11.89 |
E130119H09Rik |
RIKEN cDNA E130119H09 gene |
4458 |
0.2 |
chr8_84197696_84198961 | 11.84 |
Gm26887 |
predicted gene, 26887 |
661 |
0.38 |
chr18_60605971_60606545 | 11.78 |
Synpo |
synaptopodin |
3847 |
0.19 |
chr9_65541744_65541992 | 11.77 |
Gm17749 |
predicted gene, 17749 |
12062 |
0.13 |
chr13_63564531_63566515 | 11.75 |
Ptch1 |
patched 1 |
212 |
0.91 |
chr1_85163919_85164982 | 11.71 |
Gm6264 |
predicted gene 6264 |
3587 |
0.13 |
chr11_79071590_79071929 | 11.69 |
Ksr1 |
kinase suppressor of ras 1 |
2727 |
0.3 |
chr12_72535708_72536908 | 11.66 |
Pcnx4 |
pecanex homolog 4 |
75 |
0.97 |
chr18_36274707_36275097 | 11.56 |
Pura |
purine rich element binding protein A |
6195 |
0.2 |
chr15_83474131_83474367 | 11.54 |
Pacsin2 |
protein kinase C and casein kinase substrate in neurons 2 |
9643 |
0.14 |
chr18_67745899_67746216 | 11.53 |
Ptpn2 |
protein tyrosine phosphatase, non-receptor type 2 |
21462 |
0.13 |
chr7_144081458_144081765 | 11.48 |
Gm44999 |
predicted gene 44999 |
29474 |
0.18 |
chr9_107312801_107313233 | 11.39 |
Gm17041 |
predicted gene 17041 |
11179 |
0.09 |
chr6_113690907_113691133 | 11.32 |
Irak2 |
interleukin-1 receptor-associated kinase 2 |
275 |
0.73 |
chr18_62169193_62169548 | 11.24 |
Adrb2 |
adrenergic receptor, beta 2 |
10589 |
0.19 |
chr9_124256661_124257033 | 11.21 |
Gm39469 |
predicted gene, 39469 |
25292 |
0.16 |
chr1_125389870_125390183 | 11.20 |
Actr3 |
ARP3 actin-related protein 3 |
7586 |
0.28 |
chr15_77881916_77882084 | 11.16 |
Txn2 |
thioredoxin 2 |
33700 |
0.11 |
chr11_86380580_86380731 | 11.16 |
Med13 |
mediator complex subunit 13 |
23053 |
0.16 |
chr14_31496290_31496601 | 11.12 |
Eaf1 |
ELL associated factor 1 |
1249 |
0.3 |
chr4_106909039_106909761 | 11.10 |
Ssbp3 |
single-stranded DNA binding protein 3 |
1301 |
0.48 |
chr11_119912951_119914125 | 11.08 |
Chmp6 |
charged multivesicular body protein 6 |
97 |
0.95 |
chr13_119601169_119601466 | 11.06 |
Tmem267 |
transmembrane protein 267 |
5333 |
0.15 |
chr5_137103007_137103296 | 11.03 |
Trim56 |
tripartite motif-containing 56 |
13056 |
0.11 |
chr11_115869511_115869719 | 11.01 |
Myo15b |
myosin XVB |
7901 |
0.1 |
chr3_93597159_93597878 | 10.97 |
Gm5541 |
predicted gene 5541 |
32234 |
0.09 |
chrY_90768118_90768728 | 10.86 |
Gm21860 |
predicted gene, 21860 |
12956 |
0.16 |
chr15_79690079_79691459 | 10.79 |
Gtpbp1 |
GTP binding protein 1 |
76 |
0.92 |
chr15_77397970_77398160 | 10.77 |
Apol7a |
apolipoprotein L 7a |
386 |
0.74 |
chr6_31658824_31659102 | 10.76 |
Gm43154 |
predicted gene 43154 |
4929 |
0.2 |
chr2_32471886_32472048 | 10.75 |
Gm37169 |
predicted gene, 37169 |
16021 |
0.09 |
chr16_92399556_92400502 | 10.73 |
Rcan1 |
regulator of calcineurin 1 |
48 |
0.97 |
chr10_80137352_80138523 | 10.70 |
Cbarp |
calcium channel, voltage-dependent, beta subunit associated regulatory protein |
13 |
0.91 |
chr8_120486990_120488549 | 10.66 |
Gse1 |
genetic suppressor element 1, coiled-coil protein |
678 |
0.64 |
chr5_143561547_143562201 | 10.61 |
Fam220a |
family with sequence similarity 220, member A |
12834 |
0.14 |
chr8_83666002_83667196 | 10.51 |
Ptger1 |
prostaglandin E receptor 1 (subtype EP1) |
79 |
0.95 |
chr6_38900298_38900449 | 10.50 |
Tbxas1 |
thromboxane A synthase 1, platelet |
18607 |
0.18 |
chr5_23923860_23924147 | 10.47 |
Fam126a |
family with sequence similarity 126, member A |
1099 |
0.44 |
chr11_62005569_62005810 | 10.43 |
Specc1 |
sperm antigen with calponin homology and coiled-coil domains 1 |
339 |
0.87 |
chr5_124052205_124052548 | 10.43 |
Gm43661 |
predicted gene 43661 |
24 |
0.95 |
chr10_121904122_121904479 | 10.37 |
Gm48804 |
predicted gene, 48804 |
72242 |
0.09 |
chr7_25430237_25430677 | 10.36 |
Gm20949 |
predicted gene, 20949 |
7665 |
0.1 |
chr7_19824135_19824502 | 10.31 |
Bcl3 |
B cell leukemia/lymphoma 3 |
1548 |
0.17 |
chr5_124091870_124092203 | 10.29 |
Abcb9 |
ATP-binding cassette, sub-family B (MDR/TAP), member 9 |
1774 |
0.21 |
chr2_170209124_170209516 | 10.28 |
Zfp217 |
zinc finger protein 217 |
61217 |
0.12 |
chr14_14354416_14355184 | 10.22 |
Il3ra |
interleukin 3 receptor, alpha chain |
5179 |
0.12 |
chr17_24020724_24021065 | 10.20 |
Gm25092 |
predicted gene, 25092 |
2434 |
0.11 |
chr19_24534375_24534662 | 10.20 |
Pip5k1b |
phosphatidylinositol-4-phosphate 5-kinase, type 1 beta |
21271 |
0.17 |
chr6_137565953_137566123 | 10.19 |
Eps8 |
epidermal growth factor receptor pathway substrate 8 |
4721 |
0.26 |
chr18_73830271_73830580 | 10.17 |
Me2 |
malic enzyme 2, NAD(+)-dependent, mitochondrial |
14976 |
0.19 |
chr11_30210200_30210515 | 10.14 |
Sptbn1 |
spectrin beta, non-erythrocytic 1 |
9415 |
0.25 |
chr2_11429503_11430010 | 10.13 |
Gm13296 |
predicted gene 13296 |
9532 |
0.12 |
chr7_141372062_141372467 | 10.09 |
B230206H07Rik |
RIKEN cDNA B230206H07 gene |
7154 |
0.07 |
chr10_93666253_93666601 | 10.08 |
Gm8580 |
predicted gene 8580 |
581 |
0.67 |
chr15_102017591_102018334 | 10.03 |
Krt18 |
keratin 18 |
10218 |
0.11 |
chr16_95945355_95946015 | 10.03 |
1600002D24Rik |
RIKEN cDNA 1600002D24 gene |
16608 |
0.16 |
chr12_76558245_76558525 | 10.02 |
Plekhg3 |
pleckstrin homology domain containing, family G (with RhoGef domain) member 3 |
3853 |
0.17 |
chr4_124709070_124709499 | 10.00 |
Sf3a3 |
splicing factor 3a, subunit 3 |
5492 |
0.09 |
chr7_44777278_44777454 | 9.99 |
Gm29791 |
predicted gene, 29791 |
13282 |
0.08 |
chr7_141614114_141614913 | 9.95 |
Gm16982 |
predicted gene, 16982 |
766 |
0.53 |
chr11_83869216_83869522 | 9.93 |
Hnf1b |
HNF1 homeobox B |
16409 |
0.14 |
chr2_136920981_136921193 | 9.93 |
Slx4ip |
SLX4 interacting protein |
15544 |
0.17 |
chr7_103865767_103866083 | 9.93 |
Hbb-y |
hemoglobin Y, beta-like embryonic chain |
12709 |
0.06 |
chr12_112578742_112579004 | 9.86 |
Inf2 |
inverted formin, FH2 and WH2 domain containing |
9911 |
0.15 |
chr4_133378275_133378657 | 9.85 |
Slc9a1 |
solute carrier family 9 (sodium/hydrogen exchanger), member 1 |
7822 |
0.14 |
chr15_79684081_79684277 | 9.84 |
Gm49520 |
predicted gene, 49520 |
2857 |
0.11 |
chr1_40230393_40230707 | 9.83 |
Il1r1 |
interleukin 1 receptor, type I |
5470 |
0.21 |
chr15_103258869_103259033 | 9.80 |
Nfe2 |
nuclear factor, erythroid derived 2 |
548 |
0.61 |
chr13_30109091_30109492 | 9.79 |
Gm11367 |
predicted gene 11367 |
3183 |
0.2 |
chrY_90771840_90772811 | 9.77 |
Gm47283 |
predicted gene, 47283 |
12413 |
0.17 |
chr13_119596911_119597218 | 9.77 |
Tmem267 |
transmembrane protein 267 |
9586 |
0.14 |
chr13_20163704_20164022 | 9.75 |
Elmo1 |
engulfment and cell motility 1 |
21344 |
0.25 |
chr3_98410923_98411117 | 9.75 |
Zfp697 |
zinc finger protein 697 |
28472 |
0.12 |
chr3_79144987_79146081 | 9.75 |
Rapgef2 |
Rap guanine nucleotide exchange factor (GEF) 2 |
341 |
0.91 |
chr11_117781539_117781824 | 9.73 |
Tmc8 |
transmembrane channel-like gene family 8 |
395 |
0.49 |
chr14_14353319_14353777 | 9.72 |
Il3ra |
interleukin 3 receptor, alpha chain |
3927 |
0.13 |
chr2_79566302_79566599 | 9.72 |
Itprid2 |
ITPR interacting domain containing 2 |
68902 |
0.11 |
chr7_15948299_15949012 | 9.69 |
Nop53 |
NOP53 ribosome biogenesis factor |
2581 |
0.15 |
chr10_127508848_127510720 | 9.69 |
Stac3 |
SH3 and cysteine rich domain 3 |
2559 |
0.15 |
chr7_120865040_120865504 | 9.62 |
Gm15774 |
predicted gene 15774 |
10026 |
0.13 |
chr11_53308418_53308652 | 9.58 |
Hspa4 |
heat shock protein 4 |
8078 |
0.14 |
chr9_66894964_66895296 | 9.55 |
Rab8b |
RAB8B, member RAS oncogene family |
24557 |
0.13 |
chr19_59844292_59844601 | 9.54 |
Gm17203 |
predicted gene 17203 |
56616 |
0.13 |
chr17_83659006_83659302 | 9.54 |
Kcng3 |
potassium voltage-gated channel, subfamily G, member 3 |
27259 |
0.19 |
chr14_47533459_47534172 | 9.51 |
Fbxo34 |
F-box protein 34 |
7736 |
0.12 |
chr7_80166850_80167041 | 9.50 |
Gm45202 |
predicted gene 45202 |
11776 |
0.11 |
chr5_131814531_131814709 | 9.45 |
4930563F08Rik |
RIKEN cDNA 4930563F08 gene |
65649 |
0.08 |
chr14_25451673_25451824 | 9.42 |
Zmiz1os1 |
Zmiz1 opposite strand 1 |
6050 |
0.14 |
chr1_85250425_85250964 | 9.41 |
Gm16028 |
predicted gene 16028 |
3843 |
0.14 |
chr2_152636359_152637068 | 9.40 |
Rem1 |
rad and gem related GTP binding protein 1 |
3746 |
0.1 |
chr11_95800592_95800866 | 9.34 |
Phospho1 |
phosphatase, orphan 1 |
23770 |
0.1 |
chr6_145276262_145276713 | 9.34 |
Rps25-ps1 |
ribosomal protein S25, pseudogene 1 |
10087 |
0.1 |
chr2_26593817_26594312 | 9.31 |
Egfl7 |
EGF-like domain 7 |
1917 |
0.15 |
chr13_59795759_59796072 | 9.30 |
Tut7 |
terminal uridylyl transferase 7 |
1215 |
0.28 |
chr10_121614055_121614206 | 9.29 |
Xpot |
exportin, tRNA (nuclear export receptor for tRNAs) |
537 |
0.7 |
chr5_109557850_109558797 | 9.23 |
Crlf2 |
cytokine receptor-like factor 2 |
613 |
0.67 |
chr1_184675628_184676155 | 9.22 |
Gm38358 |
predicted gene, 38358 |
19143 |
0.14 |
chr17_29447307_29447534 | 9.22 |
Gm36199 |
predicted gene, 36199 |
1515 |
0.27 |
chr11_116571940_116572280 | 9.21 |
Ube2o |
ubiquitin-conjugating enzyme E2O |
9337 |
0.1 |
chr17_25127091_25127504 | 9.21 |
Clcn7 |
chloride channel, voltage-sensitive 7 |
6094 |
0.1 |
chr18_46324990_46325163 | 9.19 |
Ccdc112 |
coiled-coil domain containing 112 |
13148 |
0.14 |
chr5_66054485_66054755 | 9.17 |
Rbm47 |
RNA binding motif protein 47 |
68 |
0.96 |
chr1_88474625_88474848 | 9.15 |
Gm29538 |
predicted gene 29538 |
12128 |
0.15 |
chr5_36722522_36722955 | 9.14 |
Gm43701 |
predicted gene 43701 |
25880 |
0.11 |
chr12_116269475_116269737 | 9.11 |
Gm11027 |
predicted gene 11027 |
5780 |
0.13 |
chr18_82474598_82476191 | 9.11 |
Mbp |
myelin basic protein |
24 |
0.98 |
chr7_141364479_141364665 | 9.10 |
B230206H07Rik |
RIKEN cDNA B230206H07 gene |
510 |
0.56 |
chr11_30648868_30649937 | 9.06 |
Acyp2 |
acylphosphatase 2, muscle type |
185 |
0.95 |
chr4_147421334_147422151 | 8.98 |
Gm13161 |
predicted gene 13161 |
21729 |
0.12 |
chr4_130173547_130173713 | 8.97 |
Tinagl1 |
tubulointerstitial nephritis antigen-like 1 |
1061 |
0.47 |
chr11_54802300_54802451 | 8.97 |
Cdc42se2 |
CDC42 small effector 2 |
14700 |
0.13 |
chr5_15671306_15671850 | 8.93 |
Speer4cos |
spermatogenesis associated glutamate (E)-rich protein 4C, opposite strand transcript |
9132 |
0.16 |
chr8_122329580_122330425 | 8.93 |
Zfpm1 |
zinc finger protein, multitype 1 |
3696 |
0.15 |
chr5_125364959_125365129 | 8.92 |
Gm40323 |
predicted gene, 40323 |
3869 |
0.15 |
chr4_140665864_140666114 | 8.90 |
Arhgef10l |
Rho guanine nucleotide exchange factor (GEF) 10-like |
23 |
0.97 |
chr8_104602539_104603204 | 8.90 |
Cdh16 |
cadherin 16 |
10393 |
0.09 |
chr14_66089441_66089703 | 8.89 |
Adam2 |
a disintegrin and metallopeptidase domain 2 |
11839 |
0.15 |
chr16_93778190_93778348 | 8.88 |
Dop1b |
DOP1 leucine zipper like protein B |
868 |
0.55 |
chr5_107986404_107987625 | 8.88 |
Dipk1a |
divergent protein kinase domain 1A |
19 |
0.97 |
chr1_181247353_181247504 | 8.85 |
Rpl35a-ps2 |
ribosomal protein L35A, pseudogene 2 |
5108 |
0.16 |
chr11_69443424_69443606 | 8.81 |
Dnah2os |
dynein, axonemal, heavy chain 2, opposite strand |
5033 |
0.1 |
chr10_128779498_128779802 | 8.76 |
Rpsa-ps2 |
ribosomal protein SA, pseudogene 2 |
2400 |
0.13 |
chrX_130281554_130281706 | 8.73 |
Gm14984 |
predicted gene 14984 |
120589 |
0.06 |
chr10_89527130_89527354 | 8.73 |
Nr1h4 |
nuclear receptor subfamily 1, group H, member 4 |
6343 |
0.22 |
chr16_95893534_95893752 | 8.72 |
1600002D24Rik |
RIKEN cDNA 1600002D24 gene |
5070 |
0.2 |
chr9_22322453_22322618 | 8.68 |
Gm10182 |
predicted pseudogene 10182 |
1158 |
0.29 |
chr2_164431787_164431969 | 8.68 |
Sdc4 |
syndecan 4 |
11308 |
0.08 |
chr11_32251299_32251675 | 8.68 |
Nprl3 |
nitrogen permease regulator-like 3 |
1209 |
0.31 |
chr19_6278181_6278879 | 8.65 |
Ehd1 |
EH-domain containing 1 |
1605 |
0.16 |
chr2_75612969_75613570 | 8.63 |
Gm13655 |
predicted gene 13655 |
20113 |
0.15 |
chr5_146691845_146692708 | 8.61 |
4930573C15Rik |
RIKEN cDNA 4930573C15 gene |
14346 |
0.17 |
chr5_143056539_143056875 | 8.60 |
Gm43378 |
predicted gene 43378 |
6664 |
0.14 |
chr11_87749523_87749886 | 8.59 |
Mir142hg |
Mir142 host gene (non-protein coding) |
5873 |
0.09 |
chr2_5618442_5618740 | 8.59 |
Gm13216 |
predicted gene 13216 |
15020 |
0.24 |
chr12_59095476_59095647 | 8.58 |
Mia2 |
MIA SH3 domain ER export factor 2 |
238 |
0.83 |
chr2_172906256_172906593 | 8.57 |
Bmp7 |
bone morphogenetic protein 7 |
33668 |
0.15 |
chr10_81095067_81095218 | 8.56 |
Creb3l3 |
cAMP responsive element binding protein 3-like 3 |
2567 |
0.11 |
chr4_126260856_126261556 | 8.56 |
Trappc3 |
trafficking protein particle complex 3 |
1119 |
0.37 |
chr8_93229095_93229265 | 8.54 |
Ces1e |
carboxylesterase 1E |
438 |
0.77 |
chr2_168104814_168105195 | 8.54 |
AL831766.1 |
breast carcinoma amplified sequence 4 (BCAS4) pseudogene |
9873 |
0.13 |
chr5_150466046_150466511 | 8.53 |
Fry |
FRY microtubule binding protein |
5632 |
0.12 |
chr1_192061751_192061962 | 8.53 |
Traf5 |
TNF receptor-associated factor 5 |
2694 |
0.19 |
chr17_27332184_27332335 | 8.48 |
Gm10505 |
predicted gene 10505 |
82 |
0.93 |
chr15_101976894_101977736 | 8.47 |
Krt78 |
keratin 78 |
23028 |
0.09 |
chr12_24686000_24686681 | 8.43 |
Cys1 |
cystin 1 |
4527 |
0.16 |
chr5_134946861_134947243 | 8.40 |
Cldn4 |
claudin 4 |
118 |
0.91 |
chr15_103257848_103258200 | 8.38 |
Nfe2 |
nuclear factor, erythroid derived 2 |
379 |
0.75 |
chr4_41331115_41331433 | 8.38 |
Gm26084 |
predicted gene, 26084 |
14677 |
0.1 |
chr11_74826269_74826460 | 8.33 |
Mnt |
max binding protein |
4556 |
0.14 |
chr11_86607075_86607226 | 8.32 |
Vmp1 |
vacuole membrane protein 1 |
4855 |
0.17 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.3 | 21.8 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
7.0 | 28.1 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
6.8 | 20.3 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
6.7 | 20.0 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
6.3 | 6.3 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
6.1 | 6.1 | GO:0018992 | germ-line sex determination(GO:0018992) |
6.0 | 18.1 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
6.0 | 17.9 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
5.7 | 28.3 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
5.6 | 16.9 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
5.5 | 16.6 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
5.3 | 16.0 | GO:0033668 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
5.1 | 15.2 | GO:1902730 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
5.0 | 15.1 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
5.0 | 15.0 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
4.9 | 4.9 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
4.8 | 14.4 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
4.7 | 14.2 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
4.5 | 4.5 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
4.5 | 13.6 | GO:0002086 | diaphragm contraction(GO:0002086) |
4.5 | 4.5 | GO:0090335 | regulation of brown fat cell differentiation(GO:0090335) |
4.4 | 4.4 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
4.4 | 13.1 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
4.3 | 21.5 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
4.3 | 21.5 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
4.3 | 21.4 | GO:2000561 | regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) |
4.2 | 20.8 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
4.1 | 20.7 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
4.1 | 12.4 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
4.1 | 29.0 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
4.1 | 4.1 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
4.1 | 12.2 | GO:0002432 | granuloma formation(GO:0002432) |
4.0 | 24.3 | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
4.0 | 12.0 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
4.0 | 12.0 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
4.0 | 12.0 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
4.0 | 19.9 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
4.0 | 11.9 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
3.9 | 11.6 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
3.9 | 7.7 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
3.9 | 11.6 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
3.8 | 15.4 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
3.8 | 11.3 | GO:0060331 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
3.7 | 3.7 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
3.7 | 7.4 | GO:2000591 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
3.7 | 3.7 | GO:0052330 | induction of programmed cell death(GO:0012502) positive regulation of apoptotic process in other organism(GO:0044533) positive regulation by symbiont of host programmed cell death(GO:0052042) positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052330) positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052501) positive regulation of apoptotic process by virus(GO:0060139) |
3.7 | 14.8 | GO:0061687 | detoxification of inorganic compound(GO:0061687) |
3.6 | 14.6 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
3.6 | 14.2 | GO:0032264 | IMP salvage(GO:0032264) |
3.5 | 10.6 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
3.5 | 10.6 | GO:0048769 | sarcomerogenesis(GO:0048769) |
3.5 | 10.6 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
3.5 | 10.6 | GO:2000834 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
3.5 | 7.0 | GO:0003166 | bundle of His development(GO:0003166) |
3.5 | 10.5 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
3.5 | 10.5 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
3.5 | 10.4 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
3.5 | 10.4 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) |
3.5 | 3.5 | GO:0003164 | His-Purkinje system development(GO:0003164) |
3.5 | 10.4 | GO:0098700 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
3.4 | 6.8 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
3.4 | 10.2 | GO:0032782 | bile acid secretion(GO:0032782) |
3.4 | 13.5 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
3.4 | 20.3 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
3.4 | 3.4 | GO:1902263 | apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
3.3 | 13.4 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
3.3 | 40.0 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
3.3 | 9.9 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
3.3 | 6.6 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
3.2 | 9.7 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
3.2 | 6.5 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
3.2 | 9.7 | GO:0010915 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) |
3.2 | 9.7 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
3.2 | 9.6 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
3.2 | 15.9 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
3.1 | 9.4 | GO:0048207 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
3.1 | 12.5 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
3.1 | 9.4 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
3.1 | 15.6 | GO:1904970 | brush border assembly(GO:1904970) |
3.1 | 34.2 | GO:0036010 | protein localization to endosome(GO:0036010) |
3.1 | 12.4 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
3.1 | 27.8 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
3.1 | 3.1 | GO:0009750 | response to fructose(GO:0009750) cellular response to fructose stimulus(GO:0071332) |
3.1 | 3.1 | GO:0070293 | renal absorption(GO:0070293) |
3.1 | 9.2 | GO:0060319 | primitive erythrocyte differentiation(GO:0060319) |
3.0 | 12.2 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
3.0 | 18.2 | GO:0015671 | oxygen transport(GO:0015671) |
3.0 | 9.1 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
3.0 | 8.9 | GO:1903238 | positive regulation of leukocyte tethering or rolling(GO:1903238) |
3.0 | 14.9 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
3.0 | 5.9 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
3.0 | 14.8 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
3.0 | 3.0 | GO:0071688 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
2.9 | 8.8 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
2.9 | 14.7 | GO:0031659 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
2.9 | 2.9 | GO:0046321 | positive regulation of fatty acid oxidation(GO:0046321) |
2.9 | 5.8 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
2.9 | 11.7 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
2.9 | 11.6 | GO:0003176 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
2.9 | 5.8 | GO:0060318 | definitive erythrocyte differentiation(GO:0060318) |
2.9 | 14.5 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
2.9 | 5.8 | GO:0097167 | circadian regulation of translation(GO:0097167) |
2.9 | 11.5 | GO:0008228 | opsonization(GO:0008228) |
2.9 | 2.9 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
2.9 | 8.6 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
2.9 | 8.6 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
2.9 | 20.0 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
2.8 | 8.5 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
2.8 | 5.7 | GO:0036216 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
2.8 | 8.5 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
2.8 | 8.5 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
2.8 | 33.6 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
2.8 | 5.6 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
2.8 | 8.4 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
2.8 | 5.6 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
2.8 | 5.5 | GO:0045472 | response to ether(GO:0045472) |
2.8 | 5.5 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
2.8 | 2.8 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
2.8 | 11.0 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
2.7 | 5.5 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
2.7 | 13.7 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
2.7 | 8.2 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
2.7 | 10.9 | GO:0070814 | hydrogen sulfide biosynthetic process(GO:0070814) |
2.7 | 8.2 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
2.7 | 5.4 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
2.7 | 10.8 | GO:0072675 | osteoclast fusion(GO:0072675) |
2.7 | 8.1 | GO:0097460 | ferrous iron import into cell(GO:0097460) |
2.7 | 10.8 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
2.7 | 2.7 | GO:0048016 | inositol phosphate-mediated signaling(GO:0048016) |
2.7 | 8.1 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
2.7 | 13.4 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
2.7 | 5.4 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
2.7 | 2.7 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
2.7 | 8.0 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
2.7 | 5.3 | GO:0010871 | negative regulation of receptor biosynthetic process(GO:0010871) |
2.7 | 8.0 | GO:0036118 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
2.6 | 13.1 | GO:0045332 | phospholipid translocation(GO:0045332) |
2.6 | 2.6 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
2.6 | 7.8 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
2.6 | 5.2 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
2.6 | 10.3 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
2.6 | 7.7 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
2.6 | 7.7 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
2.6 | 10.3 | GO:1905206 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
2.6 | 15.4 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
2.6 | 12.8 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
2.6 | 12.8 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
2.6 | 10.2 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
2.5 | 7.6 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
2.5 | 2.5 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
2.5 | 2.5 | GO:0061511 | centriole elongation(GO:0061511) |
2.5 | 2.5 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
2.5 | 7.5 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
2.5 | 7.5 | GO:1900739 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
2.5 | 10.0 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
2.5 | 10.0 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
2.5 | 10.0 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
2.5 | 17.4 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
2.5 | 7.5 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
2.5 | 7.5 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
2.5 | 5.0 | GO:1902996 | neurofibrillary tangle assembly(GO:1902988) regulation of neurofibrillary tangle assembly(GO:1902996) |
2.5 | 7.4 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
2.5 | 14.8 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
2.5 | 2.5 | GO:1990441 | negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990441) |
2.4 | 7.3 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
2.4 | 2.4 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
2.4 | 4.9 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
2.4 | 4.8 | GO:1900086 | positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
2.4 | 7.2 | GO:0015793 | glycerol transport(GO:0015793) |
2.4 | 7.2 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
2.4 | 14.4 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
2.4 | 21.5 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
2.4 | 14.3 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
2.4 | 7.1 | GO:0043382 | positive regulation of memory T cell differentiation(GO:0043382) |
2.4 | 7.1 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
2.4 | 4.7 | GO:0035754 | B cell chemotaxis(GO:0035754) |
2.3 | 7.0 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
2.3 | 4.7 | GO:1904252 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
2.3 | 7.0 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
2.3 | 11.6 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
2.3 | 7.0 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
2.3 | 9.3 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
2.3 | 7.0 | GO:0061626 | pharyngeal arch artery morphogenesis(GO:0061626) |
2.3 | 13.9 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
2.3 | 9.2 | GO:2000389 | regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
2.3 | 11.4 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
2.3 | 6.8 | GO:0009093 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
2.3 | 2.3 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
2.3 | 4.5 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
2.3 | 9.1 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
2.3 | 2.3 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
2.2 | 18.0 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
2.2 | 22.5 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
2.2 | 6.7 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) |
2.2 | 4.5 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
2.2 | 8.9 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
2.2 | 2.2 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
2.2 | 4.4 | GO:0043173 | nucleotide salvage(GO:0043173) |
2.2 | 53.4 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
2.2 | 6.6 | GO:0048625 | myoblast fate commitment(GO:0048625) |
2.2 | 6.6 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
2.2 | 11.0 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
2.2 | 8.8 | GO:0055009 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
2.2 | 2.2 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
2.2 | 6.6 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
2.2 | 2.2 | GO:0006083 | acetate metabolic process(GO:0006083) |
2.2 | 4.3 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
2.2 | 8.6 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
2.2 | 6.5 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
2.2 | 17.2 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
2.1 | 19.2 | GO:0032060 | bleb assembly(GO:0032060) |
2.1 | 6.4 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
2.1 | 8.5 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
2.1 | 4.3 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
2.1 | 8.5 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
2.1 | 21.3 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
2.1 | 4.2 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
2.1 | 2.1 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
2.1 | 12.7 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
2.1 | 2.1 | GO:0009092 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
2.1 | 16.8 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
2.1 | 6.3 | GO:0048320 | axial mesoderm formation(GO:0048320) |
2.1 | 10.5 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
2.1 | 23.1 | GO:0070254 | mucus secretion(GO:0070254) |
2.1 | 6.3 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
2.1 | 2.1 | GO:0006706 | steroid catabolic process(GO:0006706) |
2.1 | 6.3 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
2.1 | 8.3 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
2.1 | 6.2 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
2.1 | 2.1 | GO:0002424 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
2.1 | 8.3 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
2.1 | 14.5 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
2.1 | 20.7 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
2.1 | 6.2 | GO:0060056 | mammary gland involution(GO:0060056) |
2.0 | 4.1 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
2.0 | 10.2 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
2.0 | 6.1 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
2.0 | 14.1 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
2.0 | 8.0 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
2.0 | 4.0 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
2.0 | 4.0 | GO:0032077 | positive regulation of deoxyribonuclease activity(GO:0032077) |
2.0 | 6.0 | GO:0018094 | protein polyglycylation(GO:0018094) |
2.0 | 9.9 | GO:0018101 | protein citrullination(GO:0018101) |
2.0 | 7.9 | GO:0019532 | oxalate transport(GO:0019532) |
2.0 | 4.0 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
2.0 | 2.0 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
2.0 | 5.9 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
2.0 | 3.9 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
2.0 | 3.9 | GO:2000611 | positive regulation of thyroid hormone generation(GO:2000611) |
2.0 | 3.9 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
2.0 | 19.6 | GO:0051014 | actin filament severing(GO:0051014) |
2.0 | 3.9 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
1.9 | 5.8 | GO:0045917 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
1.9 | 5.8 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
1.9 | 5.8 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
1.9 | 21.4 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
1.9 | 5.8 | GO:0006522 | alanine metabolic process(GO:0006522) pyruvate family amino acid metabolic process(GO:0009078) |
1.9 | 9.7 | GO:0006548 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
1.9 | 1.9 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
1.9 | 7.7 | GO:0031033 | myosin filament organization(GO:0031033) |
1.9 | 23.0 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
1.9 | 5.7 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
1.9 | 5.7 | GO:0070831 | basement membrane assembly(GO:0070831) |
1.9 | 1.9 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
1.9 | 9.5 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
1.9 | 9.5 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
1.9 | 5.7 | GO:1902339 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
1.9 | 5.7 | GO:0032439 | endosome localization(GO:0032439) |
1.9 | 5.6 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
1.9 | 5.6 | GO:0009826 | unidimensional cell growth(GO:0009826) |
1.9 | 3.8 | GO:0003256 | regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003256) |
1.9 | 7.5 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
1.9 | 7.5 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
1.9 | 3.7 | GO:0003383 | apical constriction(GO:0003383) |
1.9 | 1.9 | GO:0010878 | cholesterol storage(GO:0010878) |
1.9 | 11.2 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
1.9 | 5.6 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
1.9 | 3.7 | GO:1904751 | regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
1.8 | 5.5 | GO:0040031 | snRNA modification(GO:0040031) |
1.8 | 3.7 | GO:0070827 | chromatin maintenance(GO:0070827) |
1.8 | 9.2 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) |
1.8 | 1.8 | GO:0051454 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
1.8 | 23.9 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
1.8 | 1.8 | GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
1.8 | 3.7 | GO:0050955 | thermoception(GO:0050955) |
1.8 | 1.8 | GO:0038027 | apolipoprotein A-I-mediated signaling pathway(GO:0038027) |
1.8 | 3.6 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
1.8 | 1.8 | GO:0070350 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
1.8 | 5.5 | GO:0046104 | thymidine metabolic process(GO:0046104) |
1.8 | 7.3 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
1.8 | 1.8 | GO:0032741 | positive regulation of interleukin-18 production(GO:0032741) |
1.8 | 5.4 | GO:0032474 | otolith morphogenesis(GO:0032474) |
1.8 | 1.8 | GO:0046533 | negative regulation of photoreceptor cell differentiation(GO:0046533) |
1.8 | 1.8 | GO:1900368 | regulation of RNA interference(GO:1900368) |
1.8 | 1.8 | GO:0018214 | protein carboxylation(GO:0018214) |
1.8 | 1.8 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
1.8 | 1.8 | GO:0003198 | epithelial to mesenchymal transition involved in endocardial cushion formation(GO:0003198) |
1.8 | 19.7 | GO:1903392 | negative regulation of focal adhesion assembly(GO:0051895) negative regulation of adherens junction organization(GO:1903392) |
1.8 | 14.3 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
1.8 | 3.6 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
1.8 | 8.9 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
1.8 | 7.1 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
1.8 | 7.1 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
1.8 | 1.8 | GO:2000705 | regulation of dense core granule biogenesis(GO:2000705) |
1.8 | 8.8 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
1.8 | 10.6 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
1.8 | 8.8 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
1.8 | 37.0 | GO:0006301 | postreplication repair(GO:0006301) |
1.8 | 7.0 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
1.8 | 3.5 | GO:0010984 | regulation of lipoprotein particle clearance(GO:0010984) |
1.7 | 5.2 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
1.7 | 5.2 | GO:0031944 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) |
1.7 | 3.5 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
1.7 | 10.5 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
1.7 | 5.2 | GO:0060706 | cell differentiation involved in embryonic placenta development(GO:0060706) |
1.7 | 17.3 | GO:0006855 | drug transmembrane transport(GO:0006855) |
1.7 | 17.3 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
1.7 | 17.3 | GO:1901185 | negative regulation of ERBB signaling pathway(GO:1901185) |
1.7 | 5.2 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
1.7 | 8.6 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
1.7 | 24.0 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
1.7 | 3.4 | GO:0007256 | activation of JNKK activity(GO:0007256) |
1.7 | 3.4 | GO:0001807 | regulation of type IV hypersensitivity(GO:0001807) |
1.7 | 25.5 | GO:1900151 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
1.7 | 6.8 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
1.7 | 5.1 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
1.7 | 11.9 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
1.7 | 25.4 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
1.7 | 16.9 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
1.7 | 1.7 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
1.7 | 6.8 | GO:0071223 | response to lipoteichoic acid(GO:0070391) cellular response to lipoteichoic acid(GO:0071223) |
1.7 | 10.1 | GO:1904417 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
1.7 | 10.1 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
1.7 | 1.7 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
1.7 | 5.0 | GO:0035483 | gastric emptying(GO:0035483) |
1.7 | 5.0 | GO:0071316 | cellular response to nicotine(GO:0071316) |
1.7 | 5.0 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
1.7 | 10.0 | GO:0033623 | regulation of integrin activation(GO:0033623) |
1.7 | 5.0 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
1.7 | 13.4 | GO:0097286 | iron ion import(GO:0097286) |
1.7 | 1.7 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
1.7 | 16.7 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
1.7 | 13.3 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
1.7 | 3.3 | GO:1903288 | positive regulation of sodium ion export(GO:1903275) positive regulation of sodium ion export from cell(GO:1903278) regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
1.7 | 11.6 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
1.7 | 6.6 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
1.6 | 3.3 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
1.6 | 4.9 | GO:0006068 | ethanol catabolic process(GO:0006068) |
1.6 | 3.3 | GO:1901890 | positive regulation of cell junction assembly(GO:1901890) |
1.6 | 4.9 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
1.6 | 6.6 | GO:1903795 | regulation of inorganic anion transmembrane transport(GO:1903795) |
1.6 | 9.8 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
1.6 | 3.3 | GO:0071635 | negative regulation of transforming growth factor beta production(GO:0071635) |
1.6 | 4.9 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
1.6 | 3.3 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
1.6 | 3.3 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
1.6 | 14.7 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
1.6 | 4.9 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
1.6 | 1.6 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
1.6 | 1.6 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
1.6 | 9.7 | GO:0051639 | actin filament network formation(GO:0051639) |
1.6 | 4.9 | GO:0009240 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
1.6 | 6.5 | GO:0051031 | tRNA transport(GO:0051031) |
1.6 | 3.2 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
1.6 | 6.4 | GO:0046473 | phosphatidic acid biosynthetic process(GO:0006654) phosphatidic acid metabolic process(GO:0046473) |
1.6 | 4.8 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
1.6 | 9.6 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
1.6 | 9.6 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
1.6 | 9.6 | GO:0048251 | elastic fiber assembly(GO:0048251) |
1.6 | 4.8 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
1.6 | 19.0 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
1.6 | 4.8 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
1.6 | 4.8 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
1.6 | 4.7 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
1.6 | 22.0 | GO:0043486 | histone exchange(GO:0043486) |
1.6 | 11.0 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
1.6 | 1.6 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
1.6 | 11.0 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
1.6 | 7.8 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
1.6 | 17.2 | GO:0043516 | regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043516) |
1.6 | 1.6 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
1.6 | 12.5 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
1.6 | 3.1 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
1.6 | 34.2 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
1.6 | 6.2 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
1.6 | 1.6 | GO:0097242 | beta-amyloid clearance(GO:0097242) |
1.5 | 32.5 | GO:0006953 | acute-phase response(GO:0006953) |
1.5 | 1.5 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
1.5 | 3.1 | GO:1903677 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
1.5 | 12.4 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
1.5 | 13.9 | GO:0007097 | nuclear migration(GO:0007097) |
1.5 | 6.2 | GO:0009597 | detection of virus(GO:0009597) |
1.5 | 3.1 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
1.5 | 1.5 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
1.5 | 3.1 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
1.5 | 4.6 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
1.5 | 4.6 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
1.5 | 18.4 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
1.5 | 4.6 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
1.5 | 1.5 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
1.5 | 18.3 | GO:1900047 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
1.5 | 1.5 | GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) |
1.5 | 12.2 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
1.5 | 3.0 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
1.5 | 7.6 | GO:0050872 | white fat cell differentiation(GO:0050872) |
1.5 | 3.0 | GO:0036166 | phenotypic switching(GO:0036166) |
1.5 | 3.0 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
1.5 | 1.5 | GO:0007494 | midgut development(GO:0007494) |
1.5 | 3.0 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
1.5 | 6.0 | GO:0009838 | abscission(GO:0009838) |
1.5 | 3.0 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
1.5 | 9.0 | GO:0046060 | dATP metabolic process(GO:0046060) |
1.5 | 3.0 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
1.5 | 4.5 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
1.5 | 1.5 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
1.5 | 4.5 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
1.5 | 7.5 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
1.5 | 3.0 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
1.5 | 3.0 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
1.5 | 11.9 | GO:0000050 | urea cycle(GO:0000050) urea metabolic process(GO:0019627) |
1.5 | 22.3 | GO:0051084 | 'de novo' protein folding(GO:0006458) 'de novo' posttranslational protein folding(GO:0051084) |
1.5 | 10.4 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
1.5 | 5.9 | GO:0002155 | regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
1.5 | 1.5 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
1.5 | 3.0 | GO:1903984 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
1.5 | 3.0 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
1.5 | 3.0 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
1.5 | 1.5 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
1.5 | 4.4 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
1.5 | 2.9 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
1.5 | 1.5 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
1.5 | 1.5 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
1.5 | 8.8 | GO:0006525 | arginine metabolic process(GO:0006525) |
1.5 | 10.2 | GO:0030953 | astral microtubule organization(GO:0030953) |
1.5 | 4.4 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
1.5 | 1.5 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
1.5 | 1.5 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
1.5 | 4.4 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
1.5 | 1.5 | GO:0060585 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
1.5 | 10.2 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
1.5 | 10.2 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
1.5 | 1.5 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
1.5 | 1.5 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
1.5 | 2.9 | GO:1902075 | cellular response to salt(GO:1902075) |
1.5 | 5.8 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
1.5 | 4.4 | GO:0001555 | oocyte growth(GO:0001555) |
1.4 | 2.9 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
1.4 | 11.6 | GO:0031507 | heterochromatin assembly(GO:0031507) |
1.4 | 7.2 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
1.4 | 2.9 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
1.4 | 4.3 | GO:0070162 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) |
1.4 | 4.3 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
1.4 | 8.6 | GO:0071318 | cellular response to ATP(GO:0071318) |
1.4 | 7.2 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
1.4 | 14.4 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
1.4 | 23.0 | GO:0070208 | protein heterotrimerization(GO:0070208) |
1.4 | 2.9 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
1.4 | 5.7 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
1.4 | 5.7 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
1.4 | 1.4 | GO:0060620 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
1.4 | 2.8 | GO:0031652 | positive regulation of heat generation(GO:0031652) |
1.4 | 2.8 | GO:0072553 | terminal button organization(GO:0072553) |
1.4 | 1.4 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
1.4 | 4.2 | GO:0000087 | mitotic M phase(GO:0000087) |
1.4 | 4.2 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
1.4 | 8.5 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
1.4 | 2.8 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
1.4 | 8.5 | GO:0051255 | spindle midzone assembly(GO:0051255) |
1.4 | 4.2 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
1.4 | 1.4 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
1.4 | 1.4 | GO:0031052 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
1.4 | 1.4 | GO:0034287 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
1.4 | 5.6 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
1.4 | 9.7 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
1.4 | 1.4 | GO:0002884 | negative regulation of hypersensitivity(GO:0002884) |
1.4 | 11.1 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
1.4 | 4.2 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
1.4 | 4.2 | GO:0061623 | galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process from galactose(GO:0061623) |
1.4 | 1.4 | GO:0002192 | IRES-dependent translational initiation(GO:0002192) |
1.4 | 19.3 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
1.4 | 8.3 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
1.4 | 1.4 | GO:0051154 | negative regulation of striated muscle cell differentiation(GO:0051154) |
1.4 | 1.4 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
1.4 | 4.1 | GO:0001866 | NK T cell proliferation(GO:0001866) |
1.4 | 4.1 | GO:0042376 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
1.4 | 2.7 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
1.4 | 15.1 | GO:0006907 | pinocytosis(GO:0006907) |
1.4 | 8.2 | GO:0060613 | fat pad development(GO:0060613) |
1.4 | 5.5 | GO:0003091 | renal water homeostasis(GO:0003091) |
1.4 | 5.5 | GO:0060744 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
1.4 | 13.6 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
1.4 | 8.2 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
1.4 | 19.0 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) |
1.4 | 10.9 | GO:0042304 | regulation of fatty acid biosynthetic process(GO:0042304) |
1.4 | 4.1 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
1.4 | 8.1 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
1.4 | 1.4 | GO:1903423 | positive regulation of synaptic vesicle recycling(GO:1903423) |
1.4 | 4.1 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
1.4 | 17.6 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
1.3 | 6.7 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
1.3 | 4.0 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
1.3 | 1.3 | GO:0042663 | regulation of endodermal cell fate specification(GO:0042663) |
1.3 | 6.7 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
1.3 | 4.0 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
1.3 | 13.3 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
1.3 | 5.3 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
1.3 | 4.0 | GO:0042448 | progesterone metabolic process(GO:0042448) |
1.3 | 2.7 | GO:0002159 | desmosome assembly(GO:0002159) |
1.3 | 2.7 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
1.3 | 1.3 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
1.3 | 6.6 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
1.3 | 5.3 | GO:0006528 | asparagine metabolic process(GO:0006528) |
1.3 | 7.9 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
1.3 | 6.6 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
1.3 | 2.6 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
1.3 | 10.6 | GO:0046085 | adenosine metabolic process(GO:0046085) |
1.3 | 23.7 | GO:0033003 | regulation of mast cell activation(GO:0033003) |
1.3 | 7.9 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
1.3 | 7.9 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
1.3 | 40.7 | GO:0007044 | cell-substrate junction assembly(GO:0007044) |
1.3 | 2.6 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
1.3 | 6.6 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
1.3 | 3.9 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
1.3 | 1.3 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
1.3 | 1.3 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
1.3 | 3.9 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) |
1.3 | 3.9 | GO:0016264 | gap junction assembly(GO:0016264) |
1.3 | 5.2 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
1.3 | 2.6 | GO:0019530 | taurine metabolic process(GO:0019530) |
1.3 | 11.7 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
1.3 | 2.6 | GO:0001692 | histamine metabolic process(GO:0001692) |
1.3 | 1.3 | GO:0019240 | citrulline biosynthetic process(GO:0019240) |
1.3 | 3.9 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
1.3 | 2.6 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
1.3 | 24.3 | GO:0048821 | erythrocyte development(GO:0048821) |
1.3 | 1.3 | GO:0002447 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
1.3 | 5.1 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
1.3 | 2.6 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
1.3 | 10.2 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
1.3 | 2.5 | GO:0033483 | gas homeostasis(GO:0033483) |
1.3 | 3.8 | GO:1990168 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
1.3 | 1.3 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
1.3 | 6.3 | GO:0018904 | ether metabolic process(GO:0018904) |
1.3 | 2.5 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
1.3 | 5.1 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
1.3 | 8.9 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
1.3 | 1.3 | GO:0050748 | negative regulation of lipoprotein metabolic process(GO:0050748) |
1.3 | 2.5 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
1.3 | 1.3 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
1.3 | 2.5 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
1.3 | 1.3 | GO:0072053 | renal inner medulla development(GO:0072053) |
1.3 | 5.0 | GO:0002326 | B cell lineage commitment(GO:0002326) |
1.3 | 3.8 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
1.3 | 3.8 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
1.3 | 1.3 | GO:0010870 | positive regulation of receptor biosynthetic process(GO:0010870) |
1.2 | 1.2 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
1.2 | 2.5 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
1.2 | 6.2 | GO:0097421 | liver regeneration(GO:0097421) |
1.2 | 2.5 | GO:0042167 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
1.2 | 2.5 | GO:1904424 | regulation of GTP binding(GO:1904424) |
1.2 | 2.5 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
1.2 | 1.2 | GO:0048070 | regulation of developmental pigmentation(GO:0048070) |
1.2 | 1.2 | GO:0034204 | lipid translocation(GO:0034204) |
1.2 | 3.7 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
1.2 | 6.2 | GO:0008343 | adult feeding behavior(GO:0008343) |
1.2 | 3.7 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
1.2 | 6.2 | GO:0070475 | rRNA base methylation(GO:0070475) |
1.2 | 4.9 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
1.2 | 13.6 | GO:0035879 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
1.2 | 7.4 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
1.2 | 7.4 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
1.2 | 3.7 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
1.2 | 4.9 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
1.2 | 4.9 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
1.2 | 1.2 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
1.2 | 3.7 | GO:0007021 | tubulin complex assembly(GO:0007021) |
1.2 | 2.4 | GO:1902165 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902165) |
1.2 | 4.9 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
1.2 | 4.9 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
1.2 | 4.9 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
1.2 | 2.4 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
1.2 | 1.2 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
1.2 | 2.4 | GO:0035973 | aggrephagy(GO:0035973) |
1.2 | 8.5 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
1.2 | 9.7 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
1.2 | 10.9 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
1.2 | 1.2 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
1.2 | 2.4 | GO:0035733 | hepatic stellate cell activation(GO:0035733) |
1.2 | 4.8 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
1.2 | 13.3 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
1.2 | 13.2 | GO:0001945 | lymph vessel development(GO:0001945) |
1.2 | 8.4 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
1.2 | 1.2 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
1.2 | 2.4 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
1.2 | 3.6 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
1.2 | 16.8 | GO:0061436 | establishment of skin barrier(GO:0061436) |
1.2 | 6.0 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
1.2 | 6.0 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
1.2 | 6.0 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
1.2 | 4.8 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
1.2 | 4.8 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
1.2 | 3.6 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
1.2 | 15.4 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
1.2 | 3.6 | GO:0015744 | succinate transport(GO:0015744) |
1.2 | 1.2 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
1.2 | 2.4 | GO:0042148 | strand invasion(GO:0042148) |
1.2 | 5.9 | GO:0019321 | pentose metabolic process(GO:0019321) |
1.2 | 1.2 | GO:0042737 | drug catabolic process(GO:0042737) |
1.2 | 2.4 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
1.2 | 1.2 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
1.2 | 2.3 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
1.2 | 3.5 | GO:1904729 | regulation of intestinal cholesterol absorption(GO:0030300) regulation of intestinal lipid absorption(GO:1904729) |
1.2 | 3.5 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
1.2 | 1.2 | GO:0090194 | negative regulation of glomerular mesangial cell proliferation(GO:0072125) negative regulation of glomerulus development(GO:0090194) |
1.2 | 7.0 | GO:0032594 | protein transport within lipid bilayer(GO:0032594) |
1.2 | 10.5 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) |
1.2 | 3.5 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
1.2 | 2.3 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
1.2 | 1.2 | GO:0035907 | dorsal aorta development(GO:0035907) dorsal aorta morphogenesis(GO:0035912) |
1.2 | 2.3 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
1.2 | 2.3 | GO:0016556 | mRNA modification(GO:0016556) |
1.2 | 3.5 | GO:0040016 | embryonic cleavage(GO:0040016) |
1.1 | 12.6 | GO:0048535 | lymph node development(GO:0048535) |
1.1 | 6.9 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
1.1 | 2.3 | GO:0002215 | defense response to nematode(GO:0002215) |
1.1 | 3.4 | GO:0045792 | negative regulation of cell size(GO:0045792) |
1.1 | 18.3 | GO:0006308 | DNA catabolic process(GO:0006308) |
1.1 | 10.3 | GO:0030575 | nuclear body organization(GO:0030575) |
1.1 | 4.6 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
1.1 | 2.3 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
1.1 | 2.3 | GO:0042078 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
1.1 | 5.7 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
1.1 | 1.1 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
1.1 | 20.4 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
1.1 | 1.1 | GO:1901339 | activation of store-operated calcium channel activity(GO:0032237) regulation of store-operated calcium channel activity(GO:1901339) positive regulation of store-operated calcium channel activity(GO:1901341) |
1.1 | 3.4 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
1.1 | 4.5 | GO:0048539 | bone marrow development(GO:0048539) |
1.1 | 6.8 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
1.1 | 4.5 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
1.1 | 2.2 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
1.1 | 3.4 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
1.1 | 1.1 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
1.1 | 5.6 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
1.1 | 1.1 | GO:0051307 | meiotic chromosome separation(GO:0051307) |
1.1 | 1.1 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
1.1 | 3.3 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
1.1 | 11.1 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
1.1 | 5.5 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
1.1 | 1.1 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
1.1 | 7.8 | GO:0060055 | angiogenesis involved in wound healing(GO:0060055) |
1.1 | 3.3 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) |
1.1 | 3.3 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
1.1 | 2.2 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
1.1 | 17.6 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
1.1 | 3.3 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
1.1 | 2.2 | GO:0070314 | G1 to G0 transition(GO:0070314) |
1.1 | 1.1 | GO:0034241 | macrophage fusion(GO:0034238) regulation of macrophage fusion(GO:0034239) positive regulation of macrophage fusion(GO:0034241) |
1.1 | 2.2 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
1.1 | 9.8 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
1.1 | 2.2 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
1.1 | 3.3 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
1.1 | 1.1 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
1.1 | 5.4 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
1.1 | 7.6 | GO:0046688 | response to copper ion(GO:0046688) |
1.1 | 11.9 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
1.1 | 5.4 | GO:0016139 | glycoside catabolic process(GO:0016139) |
1.1 | 1.1 | GO:0090197 | chemokine secretion(GO:0090195) regulation of chemokine secretion(GO:0090196) positive regulation of chemokine secretion(GO:0090197) |
1.1 | 2.2 | GO:0006116 | NADH oxidation(GO:0006116) |
1.1 | 1.1 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
1.1 | 4.3 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
1.1 | 22.6 | GO:0044243 | multicellular organism catabolic process(GO:0044243) |
1.1 | 1.1 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
1.1 | 7.5 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
1.1 | 3.2 | GO:0046512 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
1.1 | 2.1 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
1.1 | 18.2 | GO:0006692 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
1.1 | 7.5 | GO:0046686 | response to cadmium ion(GO:0046686) |
1.1 | 3.2 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
1.1 | 3.2 | GO:0030223 | neutrophil differentiation(GO:0030223) |
1.1 | 2.1 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
1.1 | 2.1 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
1.1 | 35.2 | GO:0007569 | cell aging(GO:0007569) |
1.1 | 7.4 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
1.1 | 4.3 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
1.1 | 5.3 | GO:0009249 | protein lipoylation(GO:0009249) |
1.1 | 7.4 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
1.1 | 2.1 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
1.1 | 3.2 | GO:0006543 | glutamine catabolic process(GO:0006543) |
1.1 | 1.1 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
1.0 | 2.1 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
1.0 | 8.4 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
1.0 | 2.1 | GO:1900363 | regulation of mRNA polyadenylation(GO:1900363) |
1.0 | 6.3 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
1.0 | 2.1 | GO:0051106 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
1.0 | 6.2 | GO:0035878 | nail development(GO:0035878) |
1.0 | 6.2 | GO:0098543 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
1.0 | 2.1 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
1.0 | 2.1 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
1.0 | 3.1 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
1.0 | 1.0 | GO:1901201 | regulation of extracellular matrix assembly(GO:1901201) |
1.0 | 6.2 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
1.0 | 7.2 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
1.0 | 4.1 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
1.0 | 2.1 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
1.0 | 2.1 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
1.0 | 6.2 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
1.0 | 1.0 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
1.0 | 1.0 | GO:0033058 | directional locomotion(GO:0033058) |
1.0 | 2.0 | GO:0071865 | apoptotic process in bone marrow(GO:0071839) regulation of apoptotic process in bone marrow(GO:0071865) negative regulation of apoptotic process in bone marrow(GO:0071866) regulation of osteoclast proliferation(GO:0090289) positive regulation of osteoclast proliferation(GO:0090290) |
1.0 | 8.2 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
1.0 | 18.3 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
1.0 | 9.1 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
1.0 | 5.1 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
1.0 | 1.0 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
1.0 | 10.1 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
1.0 | 2.0 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
1.0 | 5.0 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
1.0 | 4.0 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
1.0 | 5.0 | GO:0030033 | microvillus assembly(GO:0030033) |
1.0 | 21.0 | GO:0051492 | regulation of stress fiber assembly(GO:0051492) |
1.0 | 2.0 | GO:0033227 | dsRNA transport(GO:0033227) |
1.0 | 3.0 | GO:0002441 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
1.0 | 1.0 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
1.0 | 1.0 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
1.0 | 1.0 | GO:1903204 | negative regulation of oxidative stress-induced neuron death(GO:1903204) |
1.0 | 1.0 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
1.0 | 2.0 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
1.0 | 2.0 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
1.0 | 3.0 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
1.0 | 1.0 | GO:0040033 | negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
1.0 | 4.9 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
1.0 | 2.0 | GO:0009437 | carnitine metabolic process(GO:0009437) |
1.0 | 1.0 | GO:0048143 | astrocyte activation(GO:0048143) |
1.0 | 2.0 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
1.0 | 4.9 | GO:0019217 | regulation of fatty acid metabolic process(GO:0019217) |
1.0 | 2.0 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
1.0 | 2.0 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
1.0 | 2.0 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
1.0 | 4.9 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
1.0 | 1.0 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
1.0 | 1.9 | GO:0044597 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
1.0 | 2.9 | GO:0015889 | cobalamin transport(GO:0015889) |
1.0 | 2.9 | GO:0098915 | membrane repolarization during ventricular cardiac muscle cell action potential(GO:0098915) |
1.0 | 6.8 | GO:1901796 | regulation of signal transduction by p53 class mediator(GO:1901796) |
1.0 | 1.9 | GO:0061157 | mRNA destabilization(GO:0061157) |
1.0 | 1.9 | GO:1902218 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
1.0 | 1.0 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
1.0 | 9.6 | GO:0002385 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
1.0 | 3.9 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
1.0 | 2.9 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
1.0 | 1.9 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
1.0 | 9.6 | GO:0002115 | store-operated calcium entry(GO:0002115) |
1.0 | 3.8 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
1.0 | 3.8 | GO:0046040 | IMP metabolic process(GO:0046040) |
1.0 | 4.8 | GO:0050891 | multicellular organismal water homeostasis(GO:0050891) |
1.0 | 4.8 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
1.0 | 5.7 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
1.0 | 8.6 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
1.0 | 3.8 | GO:0006561 | proline biosynthetic process(GO:0006561) |
1.0 | 2.9 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
1.0 | 6.7 | GO:0042632 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
0.9 | 25.6 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.9 | 1.9 | GO:0071468 | cellular response to acidic pH(GO:0071468) |
0.9 | 2.8 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.9 | 1.9 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.9 | 5.7 | GO:0034063 | stress granule assembly(GO:0034063) |
0.9 | 5.6 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.9 | 1.9 | GO:0006573 | valine metabolic process(GO:0006573) |
0.9 | 1.9 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.9 | 1.9 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.9 | 3.7 | GO:0045939 | negative regulation of steroid biosynthetic process(GO:0010894) negative regulation of steroid metabolic process(GO:0045939) |
0.9 | 2.8 | GO:0032570 | response to progesterone(GO:0032570) |
0.9 | 0.9 | GO:0031649 | heat generation(GO:0031649) |
0.9 | 2.8 | GO:0006152 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.9 | 0.9 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
0.9 | 9.3 | GO:0006968 | cellular defense response(GO:0006968) |
0.9 | 1.8 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
0.9 | 11.9 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.9 | 2.8 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.9 | 0.9 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.9 | 2.7 | GO:0030049 | muscle filament sliding(GO:0030049) |
0.9 | 0.9 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
0.9 | 12.8 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.9 | 16.4 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.9 | 4.5 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.9 | 4.5 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.9 | 2.7 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.9 | 2.7 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.9 | 3.6 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.9 | 1.8 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.9 | 3.6 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.9 | 2.7 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.9 | 1.8 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.9 | 0.9 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.9 | 1.8 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.9 | 3.5 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.9 | 1.8 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.9 | 0.9 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
0.9 | 7.0 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.9 | 3.5 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.9 | 0.9 | GO:0019042 | viral latency(GO:0019042) |
0.9 | 7.0 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.9 | 0.9 | GO:0019401 | alditol biosynthetic process(GO:0019401) |
0.9 | 1.7 | GO:0072310 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
0.9 | 4.3 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
0.9 | 2.6 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
0.9 | 1.7 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.9 | 5.2 | GO:0006833 | water transport(GO:0006833) |
0.9 | 0.9 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.9 | 3.5 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.9 | 1.7 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.9 | 0.9 | GO:0071899 | transcriptional activation by promoter-enhancer looping(GO:0071733) regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
0.9 | 1.7 | GO:0001757 | somite specification(GO:0001757) |
0.9 | 2.6 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.9 | 0.9 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.9 | 1.7 | GO:0043923 | modulation by host of viral transcription(GO:0043921) positive regulation by host of viral transcription(GO:0043923) modulation of transcription in other organism involved in symbiotic interaction(GO:0052312) modulation by host of symbiont transcription(GO:0052472) |
0.9 | 1.7 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.9 | 4.3 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.9 | 2.6 | GO:0015669 | gas transport(GO:0015669) |
0.9 | 6.9 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.9 | 1.7 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.9 | 2.6 | GO:0038093 | Fc receptor signaling pathway(GO:0038093) Fc-gamma receptor signaling pathway(GO:0038094) |
0.9 | 0.9 | GO:0010958 | regulation of amino acid import(GO:0010958) |
0.9 | 3.4 | GO:1902019 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.9 | 43.6 | GO:0072329 | monocarboxylic acid catabolic process(GO:0072329) |
0.9 | 2.6 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.9 | 2.6 | GO:0034333 | adherens junction assembly(GO:0034333) |
0.9 | 4.3 | GO:0009650 | UV protection(GO:0009650) |
0.9 | 6.8 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.9 | 0.9 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.8 | 0.8 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.8 | 3.4 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.8 | 8.5 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.8 | 0.8 | GO:0060128 | corticotropin hormone secreting cell differentiation(GO:0060128) |
0.8 | 0.8 | GO:0010911 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
0.8 | 1.7 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
0.8 | 23.5 | GO:0001892 | embryonic placenta development(GO:0001892) |
0.8 | 0.8 | GO:0002863 | positive regulation of inflammatory response to antigenic stimulus(GO:0002863) |
0.8 | 1.7 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.8 | 4.2 | GO:0032099 | negative regulation of appetite(GO:0032099) |
0.8 | 4.2 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.8 | 5.8 | GO:0000338 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
0.8 | 0.8 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.8 | 4.1 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.8 | 1.7 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.8 | 1.7 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.8 | 6.6 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.8 | 0.8 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.8 | 0.8 | GO:0043045 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.8 | 0.8 | GO:0071281 | cellular response to iron ion(GO:0071281) |
0.8 | 11.5 | GO:0034340 | response to type I interferon(GO:0034340) |
0.8 | 2.5 | GO:0070589 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.8 | 1.6 | GO:1901970 | positive regulation of mitotic sister chromatid separation(GO:1901970) |
0.8 | 0.8 | GO:1903431 | positive regulation of cell maturation(GO:1903431) |
0.8 | 9.8 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) |
0.8 | 9.8 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.8 | 6.6 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.8 | 3.3 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.8 | 2.4 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.8 | 1.6 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.8 | 0.8 | GO:1990791 | dorsal root ganglion development(GO:1990791) |
0.8 | 4.1 | GO:0051026 | chiasma assembly(GO:0051026) |
0.8 | 1.6 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.8 | 2.4 | GO:0033280 | response to vitamin D(GO:0033280) |
0.8 | 0.8 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.8 | 6.5 | GO:0030449 | regulation of complement activation(GO:0030449) |
0.8 | 2.4 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.8 | 0.8 | GO:0051593 | response to folic acid(GO:0051593) |
0.8 | 0.8 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
0.8 | 12.0 | GO:0014823 | response to activity(GO:0014823) |
0.8 | 1.6 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.8 | 5.6 | GO:0007141 | male meiosis I(GO:0007141) |
0.8 | 4.0 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.8 | 4.8 | GO:0045040 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
0.8 | 0.8 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.8 | 4.8 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.8 | 9.5 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.8 | 1.6 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.8 | 0.8 | GO:0044332 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.8 | 0.8 | GO:0002070 | epithelial cell maturation(GO:0002070) |
0.8 | 2.4 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.8 | 2.4 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.8 | 1.6 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.8 | 1.6 | GO:0009299 | mRNA transcription(GO:0009299) |
0.8 | 11.0 | GO:0043551 | regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
0.8 | 1.6 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.8 | 21.8 | GO:0030168 | platelet activation(GO:0030168) |
0.8 | 3.1 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.8 | 0.8 | GO:0032365 | intracellular lipid transport(GO:0032365) |
0.8 | 1.6 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.8 | 1.6 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.8 | 0.8 | GO:0048819 | regulation of hair follicle maturation(GO:0048819) |
0.8 | 0.8 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
0.8 | 9.3 | GO:0043489 | RNA stabilization(GO:0043489) |
0.8 | 3.1 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.8 | 3.9 | GO:0016266 | O-glycan processing(GO:0016266) |
0.8 | 10.8 | GO:0043297 | apical junction assembly(GO:0043297) |
0.8 | 0.8 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.8 | 1.5 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.8 | 0.8 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
0.8 | 1.5 | GO:0045585 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.8 | 1.5 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.8 | 1.5 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.8 | 8.4 | GO:0017144 | drug metabolic process(GO:0017144) |
0.8 | 3.0 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.8 | 1.5 | GO:0070488 | neutrophil aggregation(GO:0070488) |
0.8 | 3.8 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.8 | 0.8 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.8 | 3.0 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.8 | 1.5 | GO:0032252 | secretory granule localization(GO:0032252) |
0.7 | 1.5 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
0.7 | 4.5 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.7 | 2.2 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.7 | 2.2 | GO:0072512 | ferric iron transport(GO:0015682) trivalent inorganic cation transport(GO:0072512) |
0.7 | 3.0 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.7 | 0.7 | GO:2000392 | regulation of lamellipodium morphogenesis(GO:2000392) |
0.7 | 35.7 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
0.7 | 2.2 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.7 | 0.7 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.7 | 5.2 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
0.7 | 0.7 | GO:0007144 | female meiosis I(GO:0007144) |
0.7 | 2.2 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.7 | 0.7 | GO:0002434 | immune complex clearance(GO:0002434) |
0.7 | 1.5 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.7 | 0.7 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
0.7 | 5.2 | GO:0031952 | regulation of protein autophosphorylation(GO:0031952) |
0.7 | 5.9 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.7 | 0.7 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.7 | 2.2 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.7 | 0.7 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.7 | 5.1 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.7 | 4.4 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.7 | 0.7 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) cellular response to hyperoxia(GO:0071455) |
0.7 | 2.2 | GO:0008630 | intrinsic apoptotic signaling pathway in response to DNA damage(GO:0008630) |
0.7 | 5.1 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.7 | 2.2 | GO:0032875 | regulation of DNA endoreduplication(GO:0032875) |
0.7 | 2.9 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.7 | 1.4 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.7 | 1.4 | GO:0019695 | choline metabolic process(GO:0019695) |
0.7 | 1.4 | GO:0010875 | positive regulation of cholesterol efflux(GO:0010875) |
0.7 | 1.4 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.7 | 5.0 | GO:0051693 | actin filament capping(GO:0051693) |
0.7 | 14.3 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
0.7 | 1.4 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.7 | 0.7 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.7 | 0.7 | GO:0090025 | regulation of monocyte chemotaxis(GO:0090025) |
0.7 | 0.7 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.7 | 0.7 | GO:0060039 | pericardium development(GO:0060039) |
0.7 | 2.1 | GO:0034311 | sphingosine metabolic process(GO:0006670) diol metabolic process(GO:0034311) |
0.7 | 6.3 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.7 | 3.5 | GO:1903846 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.7 | 1.4 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.7 | 2.8 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.7 | 4.9 | GO:0042770 | signal transduction in response to DNA damage(GO:0042770) |
0.7 | 0.7 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.7 | 0.7 | GO:0044144 | regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
0.7 | 2.1 | GO:0060631 | regulation of meiosis I(GO:0060631) positive regulation of meiosis I(GO:0060903) |
0.7 | 2.1 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.7 | 0.7 | GO:1902415 | regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
0.7 | 1.4 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.7 | 3.5 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.7 | 9.0 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.7 | 0.7 | GO:1904752 | vascular associated smooth muscle cell migration(GO:1904738) regulation of vascular associated smooth muscle cell migration(GO:1904752) |
0.7 | 1.4 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.7 | 0.7 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
0.7 | 1.4 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.7 | 2.1 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.7 | 0.7 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.7 | 4.1 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.7 | 1.4 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
0.7 | 8.2 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.7 | 0.7 | GO:1901723 | negative regulation of cell proliferation involved in kidney development(GO:1901723) |
0.7 | 0.7 | GO:0061622 | glycolytic process through glucose-1-phosphate(GO:0061622) |
0.7 | 2.0 | GO:0035284 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.7 | 1.4 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.7 | 29.8 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.7 | 0.7 | GO:1904683 | regulation of metalloendopeptidase activity(GO:1904683) negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
0.7 | 4.1 | GO:0032967 | positive regulation of collagen biosynthetic process(GO:0032967) |
0.7 | 2.7 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.7 | 2.0 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.7 | 4.0 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.7 | 2.7 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.7 | 6.7 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.7 | 1.3 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.7 | 1.3 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
0.7 | 2.0 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.7 | 2.0 | GO:0051775 | response to redox state(GO:0051775) |
0.7 | 2.0 | GO:0003299 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.7 | 2.7 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) positive regulation of melanocyte differentiation(GO:0045636) |
0.7 | 2.0 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.7 | 3.3 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.7 | 7.3 | GO:0007131 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.7 | 2.6 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.7 | 5.3 | GO:0050926 | regulation of positive chemotaxis(GO:0050926) |
0.7 | 1.3 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.7 | 2.0 | GO:0015886 | heme transport(GO:0015886) |
0.7 | 2.6 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.7 | 4.6 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.7 | 10.5 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.7 | 0.7 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.7 | 2.0 | GO:0030878 | thyroid gland development(GO:0030878) |
0.7 | 2.0 | GO:0016093 | polyprenol metabolic process(GO:0016093) dolichol metabolic process(GO:0019348) |
0.7 | 2.6 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.7 | 0.7 | GO:0046348 | amino sugar catabolic process(GO:0046348) |
0.7 | 1.3 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.6 | 2.6 | GO:0000012 | single strand break repair(GO:0000012) |
0.6 | 1.3 | GO:0046719 | regulation by virus of viral protein levels in host cell(GO:0046719) |
0.6 | 12.3 | GO:0001523 | retinoid metabolic process(GO:0001523) |
0.6 | 1.9 | GO:0007525 | somatic muscle development(GO:0007525) |
0.6 | 11.0 | GO:0019319 | hexose biosynthetic process(GO:0019319) |
0.6 | 0.6 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) |
0.6 | 3.9 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.6 | 0.6 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.6 | 1.3 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.6 | 3.8 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.6 | 1.9 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.6 | 1.9 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.6 | 1.9 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.6 | 2.5 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.6 | 5.1 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.6 | 1.3 | GO:0072672 | neutrophil extravasation(GO:0072672) |
0.6 | 0.6 | GO:0060967 | negative regulation of posttranscriptional gene silencing(GO:0060149) negative regulation of gene silencing by RNA(GO:0060967) |
0.6 | 0.6 | GO:0032366 | intracellular sterol transport(GO:0032366) |
0.6 | 3.8 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.6 | 1.3 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.6 | 5.6 | GO:0061088 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.6 | 1.9 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.6 | 0.6 | GO:2000192 | negative regulation of fatty acid transport(GO:2000192) |
0.6 | 0.6 | GO:0010159 | specification of organ position(GO:0010159) |
0.6 | 1.9 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.6 | 1.9 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
0.6 | 0.6 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.6 | 1.9 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.6 | 0.6 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.6 | 2.5 | GO:0030038 | contractile actin filament bundle assembly(GO:0030038) stress fiber assembly(GO:0043149) |
0.6 | 1.2 | GO:0002551 | mast cell chemotaxis(GO:0002551) |
0.6 | 5.5 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.6 | 2.5 | GO:0050832 | defense response to fungus(GO:0050832) |
0.6 | 3.7 | GO:0010561 | negative regulation of glycoprotein biosynthetic process(GO:0010561) |
0.6 | 1.8 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.6 | 5.5 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.6 | 1.8 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.6 | 2.4 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.6 | 1.8 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.6 | 1.8 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
0.6 | 6.6 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.6 | 1.2 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.6 | 0.6 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.6 | 4.8 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.6 | 1.8 | GO:0016322 | neuron remodeling(GO:0016322) |
0.6 | 34.0 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.6 | 2.4 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.6 | 14.2 | GO:0031424 | keratinization(GO:0031424) |
0.6 | 8.3 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.6 | 1.2 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.6 | 1.2 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.6 | 1.2 | GO:0034969 | histone arginine methylation(GO:0034969) |
0.6 | 0.6 | GO:0071351 | response to interleukin-18(GO:0070673) cellular response to interleukin-18(GO:0071351) |
0.6 | 10.6 | GO:0007520 | myoblast fusion(GO:0007520) |
0.6 | 2.3 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.6 | 7.6 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.6 | 2.3 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.6 | 1.2 | GO:0072606 | interleukin-8 secretion(GO:0072606) |
0.6 | 0.6 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.6 | 6.4 | GO:1902285 | semaphorin-plexin signaling pathway involved in neuron projection guidance(GO:1902285) semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
0.6 | 1.2 | GO:0006825 | copper ion transport(GO:0006825) |
0.6 | 5.8 | GO:0001836 | release of cytochrome c from mitochondria(GO:0001836) |
0.6 | 1.7 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.6 | 0.6 | GO:0015780 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.6 | 0.6 | GO:2001138 | regulation of phospholipid transport(GO:2001138) positive regulation of phospholipid transport(GO:2001140) |
0.6 | 2.9 | GO:1901978 | positive regulation of cell cycle checkpoint(GO:1901978) |
0.6 | 1.7 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.6 | 2.9 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.6 | 0.6 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.6 | 0.6 | GO:0090231 | regulation of spindle checkpoint(GO:0090231) |
0.6 | 1.1 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.6 | 0.6 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.6 | 0.6 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.6 | 1.1 | GO:0061045 | negative regulation of wound healing(GO:0061045) |
0.6 | 0.6 | GO:0032096 | negative regulation of response to food(GO:0032096) |
0.6 | 5.1 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.6 | 2.3 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.6 | 12.4 | GO:0007091 | metaphase/anaphase transition of mitotic cell cycle(GO:0007091) metaphase/anaphase transition of cell cycle(GO:0044784) |
0.6 | 1.1 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.6 | 0.6 | GO:0001907 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
0.6 | 2.2 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.6 | 3.9 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.6 | 1.1 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.6 | 1.7 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.6 | 1.7 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.6 | 1.1 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.6 | 6.1 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.6 | 1.1 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.6 | 2.2 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.6 | 1.7 | GO:0046929 | negative regulation of neurotransmitter secretion(GO:0046929) |
0.6 | 1.7 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.6 | 0.6 | GO:0042362 | fat-soluble vitamin biosynthetic process(GO:0042362) |
0.6 | 1.1 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.6 | 1.7 | GO:0034121 | regulation of toll-like receptor signaling pathway(GO:0034121) |
0.5 | 1.1 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
0.5 | 3.8 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.5 | 1.1 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.5 | 2.2 | GO:0070305 | response to cGMP(GO:0070305) |
0.5 | 1.1 | GO:0003352 | regulation of cilium movement(GO:0003352) |
0.5 | 2.2 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.5 | 24.3 | GO:0007030 | Golgi organization(GO:0007030) |
0.5 | 2.7 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.5 | 1.6 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.5 | 1.6 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.5 | 1.6 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.5 | 2.7 | GO:0060539 | diaphragm development(GO:0060539) |
0.5 | 1.6 | GO:0009629 | response to gravity(GO:0009629) |
0.5 | 1.1 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.5 | 9.6 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
0.5 | 0.5 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.5 | 0.5 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.5 | 2.1 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.5 | 0.5 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.5 | 8.5 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.5 | 1.6 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.5 | 2.1 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.5 | 0.5 | GO:0070316 | G0 to G1 transition(GO:0045023) regulation of G0 to G1 transition(GO:0070316) |
0.5 | 0.5 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.5 | 4.2 | GO:0032355 | response to estradiol(GO:0032355) |
0.5 | 8.9 | GO:0015914 | phospholipid transport(GO:0015914) |
0.5 | 4.2 | GO:0008272 | sulfate transport(GO:0008272) |
0.5 | 8.4 | GO:1901988 | negative regulation of cell cycle phase transition(GO:1901988) |
0.5 | 0.5 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.5 | 1.0 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.5 | 9.9 | GO:0048286 | lung alveolus development(GO:0048286) |
0.5 | 1.6 | GO:0046173 | polyol biosynthetic process(GO:0046173) |
0.5 | 2.1 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.5 | 0.5 | GO:1903750 | regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
0.5 | 3.6 | GO:1902235 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
0.5 | 1.0 | GO:0043400 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) positive regulation of cortisol secretion(GO:0051464) |
0.5 | 2.1 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.5 | 1.0 | GO:0002675 | positive regulation of acute inflammatory response(GO:0002675) |
0.5 | 2.6 | GO:0046036 | CTP biosynthetic process(GO:0006241) pyrimidine ribonucleoside triphosphate metabolic process(GO:0009208) pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) CTP metabolic process(GO:0046036) |
0.5 | 1.0 | GO:0010755 | regulation of plasminogen activation(GO:0010755) |
0.5 | 1.0 | GO:2000047 | regulation of cell-cell adhesion mediated by cadherin(GO:2000047) |
0.5 | 1.5 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.5 | 0.5 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.5 | 1.0 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
0.5 | 0.5 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
0.5 | 1.0 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.5 | 4.1 | GO:1904814 | regulation of protein localization to chromosome, telomeric region(GO:1904814) positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
0.5 | 2.0 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.5 | 3.6 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.5 | 4.6 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.5 | 5.6 | GO:0043462 | regulation of ATPase activity(GO:0043462) |
0.5 | 3.0 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.5 | 2.0 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
0.5 | 1.0 | GO:0046640 | regulation of alpha-beta T cell proliferation(GO:0046640) |
0.5 | 1.5 | GO:0014829 | vascular smooth muscle contraction(GO:0014829) |
0.5 | 2.5 | GO:1902750 | negative regulation of cell cycle G2/M phase transition(GO:1902750) |
0.5 | 1.5 | GO:0001953 | negative regulation of cell-matrix adhesion(GO:0001953) |
0.5 | 2.0 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.5 | 2.0 | GO:0010390 | histone monoubiquitination(GO:0010390) |
0.5 | 0.5 | GO:0032677 | regulation of interleukin-8 production(GO:0032677) |
0.5 | 3.5 | GO:0021924 | cell proliferation in hindbrain(GO:0021534) cell proliferation in external granule layer(GO:0021924) cerebellar granule cell precursor proliferation(GO:0021930) |
0.5 | 4.0 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.5 | 0.5 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.5 | 1.5 | GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:0000288) |
0.5 | 2.0 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.5 | 0.5 | GO:1903337 | positive regulation of vacuolar transport(GO:1903337) |
0.5 | 2.5 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.5 | 3.0 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.5 | 2.0 | GO:0042533 | tumor necrosis factor biosynthetic process(GO:0042533) regulation of tumor necrosis factor biosynthetic process(GO:0042534) |
0.5 | 5.4 | GO:0001706 | endoderm formation(GO:0001706) |
0.5 | 1.5 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.5 | 1.0 | GO:1900620 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
0.5 | 3.4 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.5 | 1.9 | GO:2001242 | regulation of intrinsic apoptotic signaling pathway(GO:2001242) |
0.5 | 3.4 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.5 | 0.5 | GO:0033026 | negative regulation of mast cell apoptotic process(GO:0033026) |
0.5 | 2.4 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.5 | 0.5 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.5 | 5.3 | GO:0016180 | snRNA processing(GO:0016180) |
0.5 | 1.0 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.5 | 2.4 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.5 | 1.0 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.5 | 0.5 | GO:0010841 | positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) |
0.5 | 1.0 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.5 | 1.4 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.5 | 1.4 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
0.5 | 3.3 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.5 | 1.4 | GO:0015819 | lysine transport(GO:0015819) |
0.5 | 2.8 | GO:1901661 | quinone metabolic process(GO:1901661) |
0.5 | 0.9 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.5 | 0.9 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.5 | 1.4 | GO:0060526 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.5 | 0.9 | GO:0002176 | male germ cell proliferation(GO:0002176) |
0.5 | 0.5 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
0.5 | 0.9 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.5 | 1.9 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.5 | 3.3 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.5 | 3.3 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.5 | 7.0 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.5 | 0.5 | GO:0070949 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.5 | 4.2 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.5 | 1.9 | GO:0010039 | response to iron ion(GO:0010039) |
0.5 | 0.5 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.5 | 3.7 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
0.5 | 0.9 | GO:0032098 | regulation of appetite(GO:0032098) |
0.5 | 15.2 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.5 | 0.5 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.5 | 4.6 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
0.5 | 1.4 | GO:0002591 | positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) |
0.5 | 0.5 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.5 | 4.1 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.5 | 1.4 | GO:0033762 | response to glucagon(GO:0033762) |
0.5 | 1.4 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.5 | 3.6 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.5 | 6.3 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.5 | 0.5 | GO:0035729 | response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
0.5 | 0.9 | GO:0035404 | histone-serine phosphorylation(GO:0035404) histone H3-S28 phosphorylation(GO:0043988) |
0.5 | 16.2 | GO:1901800 | positive regulation of proteasomal protein catabolic process(GO:1901800) |
0.4 | 0.9 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
0.4 | 1.3 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
0.4 | 1.8 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.4 | 0.4 | GO:0060442 | branching involved in prostate gland morphogenesis(GO:0060442) |
0.4 | 1.3 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.4 | 0.9 | GO:0090208 | positive regulation of triglyceride metabolic process(GO:0090208) |
0.4 | 5.7 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.4 | 0.4 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.4 | 3.5 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.4 | 4.8 | GO:0006465 | signal peptide processing(GO:0006465) |
0.4 | 0.4 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.4 | 1.3 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.4 | 12.6 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.4 | 0.4 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.4 | 1.3 | GO:0061117 | negative regulation of cardiac muscle tissue growth(GO:0055022) negative regulation of heart growth(GO:0061117) |
0.4 | 2.6 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.4 | 0.9 | GO:0032964 | collagen biosynthetic process(GO:0032964) |
0.4 | 1.3 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.4 | 0.4 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.4 | 0.9 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.4 | 2.6 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) |
0.4 | 3.0 | GO:1902653 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
0.4 | 1.3 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.4 | 1.3 | GO:0060177 | regulation of angiotensin metabolic process(GO:0060177) |
0.4 | 0.8 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.4 | 1.7 | GO:0015825 | L-serine transport(GO:0015825) |
0.4 | 0.8 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.4 | 1.7 | GO:0051156 | pentose-phosphate shunt(GO:0006098) glucose 6-phosphate metabolic process(GO:0051156) |
0.4 | 0.4 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.4 | 0.4 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
0.4 | 3.8 | GO:0051383 | kinetochore organization(GO:0051383) |
0.4 | 1.7 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
0.4 | 0.4 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.4 | 0.4 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) regulation of hemoglobin biosynthetic process(GO:0046984) |
0.4 | 0.8 | GO:0045297 | mating plug formation(GO:0042628) single-organism reproductive behavior(GO:0044704) post-mating behavior(GO:0045297) |
0.4 | 3.7 | GO:0071456 | cellular response to hypoxia(GO:0071456) |
0.4 | 3.3 | GO:0048661 | positive regulation of smooth muscle cell proliferation(GO:0048661) |
0.4 | 4.1 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
0.4 | 0.8 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.4 | 0.8 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.4 | 0.4 | GO:2000318 | positive regulation of T-helper 17 type immune response(GO:2000318) |
0.4 | 0.4 | GO:0034651 | cortisol biosynthetic process(GO:0034651) |
0.4 | 0.4 | GO:0042637 | catagen(GO:0042637) |
0.4 | 2.9 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.4 | 1.2 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.4 | 2.0 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
0.4 | 20.8 | GO:0098792 | xenophagy(GO:0098792) |
0.4 | 0.8 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.4 | 0.8 | GO:0045986 | negative regulation of smooth muscle contraction(GO:0045986) |
0.4 | 1.2 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.4 | 0.4 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) |
0.4 | 0.8 | GO:0007127 | meiosis I(GO:0007127) |
0.4 | 1.6 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.4 | 3.6 | GO:0090280 | positive regulation of calcium ion import(GO:0090280) |
0.4 | 0.4 | GO:0046864 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.4 | 5.6 | GO:0007093 | mitotic cell cycle checkpoint(GO:0007093) |
0.4 | 0.8 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.4 | 4.0 | GO:0009395 | phospholipid catabolic process(GO:0009395) |
0.4 | 0.4 | GO:0002921 | negative regulation of humoral immune response(GO:0002921) |
0.4 | 2.0 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.4 | 4.4 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.4 | 2.4 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.4 | 4.4 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
0.4 | 0.4 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.4 | 0.4 | GO:0045346 | MHC class I biosynthetic process(GO:0045341) MHC class II biosynthetic process(GO:0045342) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) regulation of MHC class II biosynthetic process(GO:0045346) |
0.4 | 1.6 | GO:0042508 | tyrosine phosphorylation of Stat1 protein(GO:0042508) |
0.4 | 0.4 | GO:0070168 | negative regulation of biomineral tissue development(GO:0070168) |
0.4 | 0.4 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.4 | 0.4 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.4 | 1.2 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.4 | 3.1 | GO:0031648 | protein destabilization(GO:0031648) |
0.4 | 9.4 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.4 | 0.4 | GO:2000510 | regulation of dendritic cell chemotaxis(GO:2000508) positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.4 | 3.1 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.4 | 4.7 | GO:0030239 | myofibril assembly(GO:0030239) |
0.4 | 3.1 | GO:0002347 | response to tumor cell(GO:0002347) |
0.4 | 0.4 | GO:0061209 | cell proliferation involved in mesonephros development(GO:0061209) |
0.4 | 2.7 | GO:0016926 | protein desumoylation(GO:0016926) |
0.4 | 0.8 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.4 | 1.2 | GO:0045830 | positive regulation of isotype switching(GO:0045830) |
0.4 | 4.2 | GO:0010634 | positive regulation of epithelial cell migration(GO:0010634) |
0.4 | 1.5 | GO:1902175 | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902175) |
0.4 | 0.4 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.4 | 1.1 | GO:0015871 | choline transport(GO:0015871) |
0.4 | 0.8 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
0.4 | 0.4 | GO:0090077 | foam cell differentiation(GO:0090077) |
0.4 | 0.8 | GO:0007000 | nucleolus organization(GO:0007000) |
0.4 | 1.9 | GO:0030318 | melanocyte differentiation(GO:0030318) |
0.4 | 2.7 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.4 | 20.7 | GO:0051028 | mRNA transport(GO:0051028) |
0.4 | 1.5 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.4 | 1.9 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.4 | 1.1 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.4 | 0.7 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.4 | 0.4 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.4 | 26.7 | GO:0006631 | fatty acid metabolic process(GO:0006631) |
0.4 | 1.1 | GO:0048875 | chemical homeostasis within a tissue(GO:0048875) |
0.4 | 1.5 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.4 | 1.1 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.4 | 0.7 | GO:1901722 | regulation of cell proliferation involved in kidney development(GO:1901722) |
0.4 | 0.4 | GO:0007567 | parturition(GO:0007567) |
0.4 | 0.7 | GO:0033182 | regulation of histone ubiquitination(GO:0033182) |
0.4 | 2.9 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.4 | 10.9 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.4 | 0.4 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.4 | 0.4 | GO:0009445 | putrescine metabolic process(GO:0009445) |
0.4 | 0.7 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.4 | 0.4 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
0.4 | 0.4 | GO:0051197 | positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
0.4 | 0.4 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.4 | 1.4 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
0.4 | 11.4 | GO:0007599 | hemostasis(GO:0007599) |
0.4 | 2.8 | GO:0042537 | benzene-containing compound metabolic process(GO:0042537) |
0.4 | 0.7 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.4 | 3.5 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.3 | 1.0 | GO:0051055 | negative regulation of lipid biosynthetic process(GO:0051055) |
0.3 | 1.7 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.3 | 71.5 | GO:0008380 | RNA splicing(GO:0008380) |
0.3 | 0.7 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.3 | 1.0 | GO:0072678 | T cell migration(GO:0072678) |
0.3 | 1.7 | GO:0001659 | temperature homeostasis(GO:0001659) |
0.3 | 0.3 | GO:0018377 | protein myristoylation(GO:0018377) |
0.3 | 1.7 | GO:0045604 | regulation of epidermal cell differentiation(GO:0045604) |
0.3 | 3.4 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.3 | 0.3 | GO:0072718 | response to cisplatin(GO:0072718) |
0.3 | 1.7 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.3 | 1.4 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.3 | 7.8 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.3 | 0.3 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.3 | 5.4 | GO:0042035 | regulation of cytokine biosynthetic process(GO:0042035) |
0.3 | 2.0 | GO:0071624 | positive regulation of granulocyte chemotaxis(GO:0071624) |
0.3 | 1.7 | GO:0046889 | positive regulation of lipid biosynthetic process(GO:0046889) |
0.3 | 0.7 | GO:0002586 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) |
0.3 | 1.3 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.3 | 0.3 | GO:1902414 | protein localization to adherens junction(GO:0071896) protein localization to cell junction(GO:1902414) |
0.3 | 0.7 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.3 | 1.0 | GO:0046836 | glycolipid transport(GO:0046836) |
0.3 | 1.3 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.3 | 6.5 | GO:1902652 | secondary alcohol metabolic process(GO:1902652) |
0.3 | 0.7 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.3 | 1.0 | GO:1900426 | regulation of antimicrobial humoral response(GO:0002759) positive regulation of defense response to bacterium(GO:1900426) |
0.3 | 1.6 | GO:0046606 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.3 | 4.9 | GO:0060323 | head morphogenesis(GO:0060323) |
0.3 | 0.3 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.3 | 4.5 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.3 | 6.8 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.3 | 0.3 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
0.3 | 0.3 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.3 | 0.6 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.3 | 0.3 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.3 | 1.3 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
0.3 | 3.2 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.3 | 1.6 | GO:0010613 | positive regulation of cardiac muscle hypertrophy(GO:0010613) positive regulation of muscle hypertrophy(GO:0014742) |
0.3 | 0.3 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
0.3 | 0.9 | GO:0015884 | folic acid transport(GO:0015884) |
0.3 | 0.3 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.3 | 1.2 | GO:0002021 | response to dietary excess(GO:0002021) |
0.3 | 8.6 | GO:0051225 | spindle assembly(GO:0051225) |
0.3 | 0.3 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.3 | 0.6 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.3 | 0.6 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.3 | 0.6 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.3 | 0.3 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.3 | 4.2 | GO:0006491 | N-glycan processing(GO:0006491) |
0.3 | 1.5 | GO:1903052 | positive regulation of proteolysis involved in cellular protein catabolic process(GO:1903052) |
0.3 | 2.1 | GO:0070206 | protein trimerization(GO:0070206) |
0.3 | 2.4 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.3 | 0.3 | GO:0071698 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.3 | 0.9 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.3 | 0.6 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.3 | 0.3 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.3 | 0.9 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.3 | 0.3 | GO:0021603 | cranial nerve formation(GO:0021603) |
0.3 | 0.3 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.3 | 13.7 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.3 | 0.6 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.3 | 0.6 | GO:0002579 | positive regulation of antigen processing and presentation(GO:0002579) |
0.3 | 0.8 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.3 | 0.8 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.3 | 3.9 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.3 | 1.1 | GO:0046629 | gamma-delta T cell activation(GO:0046629) |
0.3 | 0.8 | GO:0006882 | cellular zinc ion homeostasis(GO:0006882) |
0.3 | 4.2 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.3 | 0.5 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.3 | 0.3 | GO:0032727 | positive regulation of interferon-alpha production(GO:0032727) |
0.3 | 0.3 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.3 | 1.9 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.3 | 0.3 | GO:0050931 | pigment cell differentiation(GO:0050931) |
0.3 | 0.3 | GO:0009247 | glycolipid biosynthetic process(GO:0009247) |
0.3 | 2.4 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.3 | 0.5 | GO:0072180 | mesonephric duct morphogenesis(GO:0072180) |
0.3 | 5.0 | GO:0051321 | meiotic cell cycle(GO:0051321) |
0.3 | 0.8 | GO:0019086 | late viral transcription(GO:0019086) |
0.3 | 2.1 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.3 | 1.3 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.3 | 0.3 | GO:0051299 | centrosome separation(GO:0051299) |
0.3 | 4.4 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.3 | 0.3 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.3 | 0.5 | GO:0006848 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.3 | 2.8 | GO:0009268 | response to pH(GO:0009268) |
0.3 | 0.3 | GO:0009624 | response to nematode(GO:0009624) |
0.3 | 0.5 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.3 | 0.3 | GO:0046174 | polyol catabolic process(GO:0046174) |
0.3 | 1.0 | GO:0050657 | nucleic acid transport(GO:0050657) RNA transport(GO:0050658) |
0.3 | 5.1 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.3 | 3.8 | GO:0030488 | tRNA methylation(GO:0030488) |
0.3 | 0.3 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.2 | 0.2 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.2 | 0.2 | GO:0009200 | deoxyribonucleoside triphosphate metabolic process(GO:0009200) |
0.2 | 0.7 | GO:0070989 | oxidative demethylation(GO:0070989) |
0.2 | 1.0 | GO:0030091 | protein repair(GO:0030091) |
0.2 | 5.1 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.2 | 0.7 | GO:0015893 | drug transport(GO:0015893) |
0.2 | 0.2 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.2 | 3.4 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.2 | 0.5 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.2 | 0.9 | GO:0043618 | regulation of transcription from RNA polymerase II promoter in response to stress(GO:0043618) |
0.2 | 0.2 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.2 | 0.5 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.2 | 0.5 | GO:0006450 | regulation of translational elongation(GO:0006448) regulation of translational fidelity(GO:0006450) |
0.2 | 1.6 | GO:0033866 | nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.2 | 2.6 | GO:2001243 | negative regulation of intrinsic apoptotic signaling pathway(GO:2001243) |
0.2 | 5.4 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.2 | 2.6 | GO:0015931 | nucleobase-containing compound transport(GO:0015931) |
0.2 | 0.7 | GO:1903318 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
0.2 | 0.2 | GO:0051132 | NK T cell activation(GO:0051132) |
0.2 | 0.9 | GO:1902743 | regulation of lamellipodium organization(GO:1902743) |
0.2 | 2.3 | GO:0042246 | tissue regeneration(GO:0042246) |
0.2 | 0.5 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.2 | 2.0 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.2 | 5.6 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.2 | 4.3 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.2 | 0.2 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.2 | 2.2 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.2 | 0.2 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.2 | 0.4 | GO:0015846 | polyamine transport(GO:0015846) |
0.2 | 1.1 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.2 | 1.1 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.2 | 0.2 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.2 | 1.1 | GO:0071347 | cellular response to interleukin-1(GO:0071347) |
0.2 | 18.9 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.2 | 0.9 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.2 | 2.8 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.2 | 0.6 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.2 | 1.3 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.2 | 0.2 | GO:0007418 | ventral midline development(GO:0007418) floor plate morphogenesis(GO:0033505) |
0.2 | 0.2 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.2 | 0.4 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.2 | 0.6 | GO:0097009 | energy homeostasis(GO:0097009) |
0.2 | 0.4 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.2 | 0.2 | GO:0097709 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.2 | 0.2 | GO:0032816 | positive regulation of natural killer cell activation(GO:0032816) |
0.2 | 0.6 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.2 | 3.5 | GO:0033077 | T cell differentiation in thymus(GO:0033077) thymocyte aggregation(GO:0071594) |
0.2 | 0.6 | GO:0010454 | negative regulation of cell fate commitment(GO:0010454) |
0.2 | 0.8 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.2 | 1.0 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
0.2 | 0.2 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.2 | 0.8 | GO:0090151 | protein import into mitochondrial inner membrane(GO:0045039) establishment of protein localization to mitochondrial membrane(GO:0090151) |
0.2 | 1.6 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.2 | 0.8 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.2 | 0.2 | GO:0048793 | pronephros development(GO:0048793) |
0.2 | 1.4 | GO:0051168 | nuclear export(GO:0051168) |
0.2 | 0.2 | GO:0033275 | actin-myosin filament sliding(GO:0033275) |
0.2 | 0.4 | GO:0046325 | negative regulation of glucose transport(GO:0010829) negative regulation of glucose import(GO:0046325) |
0.2 | 1.8 | GO:0032527 | protein exit from endoplasmic reticulum(GO:0032527) |
0.2 | 0.2 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.2 | 1.4 | GO:0055006 | cardiac cell development(GO:0055006) |
0.2 | 1.0 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.2 | 0.4 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.2 | 0.8 | GO:0045141 | meiotic telomere clustering(GO:0045141) |
0.2 | 0.7 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.2 | 0.6 | GO:0014857 | regulation of skeletal muscle cell proliferation(GO:0014857) |
0.2 | 0.6 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.2 | 0.4 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
0.2 | 0.4 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.2 | 1.1 | GO:1904030 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.2 | 2.5 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.2 | 0.4 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.2 | 0.2 | GO:0042482 | positive regulation of odontogenesis(GO:0042482) |
0.2 | 0.4 | GO:0006809 | nitric oxide biosynthetic process(GO:0006809) regulation of nitric oxide biosynthetic process(GO:0045428) |
0.2 | 0.7 | GO:0051013 | microtubule severing(GO:0051013) |
0.2 | 0.2 | GO:0072048 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
0.2 | 0.3 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.2 | 0.2 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.2 | 0.3 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
0.2 | 0.5 | GO:0048599 | oocyte development(GO:0048599) |
0.2 | 0.3 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
0.2 | 0.2 | GO:0090269 | fibroblast growth factor production(GO:0090269) regulation of fibroblast growth factor production(GO:0090270) |
0.2 | 1.2 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.2 | 0.3 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.2 | 0.3 | GO:0044851 | hair cycle phase(GO:0044851) |
0.2 | 1.6 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.2 | 0.2 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.2 | 0.3 | GO:0018343 | protein farnesylation(GO:0018343) |
0.2 | 0.6 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.2 | 0.5 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.2 | 0.3 | GO:1903364 | positive regulation of cellular protein catabolic process(GO:1903364) |
0.2 | 0.3 | GO:0060065 | uterus development(GO:0060065) |
0.2 | 0.5 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.2 | 0.6 | GO:0042559 | pteridine-containing compound biosynthetic process(GO:0042559) |
0.2 | 0.2 | GO:0044838 | cell quiescence(GO:0044838) |
0.2 | 0.5 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.2 | 1.5 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.1 | GO:0002584 | negative regulation of antigen processing and presentation(GO:0002578) negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
0.1 | 3.3 | GO:0031929 | TOR signaling(GO:0031929) |
0.1 | 0.1 | GO:0009620 | response to fungus(GO:0009620) |
0.1 | 0.3 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.1 | 1.4 | GO:0051591 | response to cAMP(GO:0051591) |
0.1 | 2.1 | GO:0030838 | positive regulation of actin filament polymerization(GO:0030838) |
0.1 | 1.9 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.1 | 0.1 | GO:0050810 | regulation of steroid biosynthetic process(GO:0050810) |
0.1 | 4.1 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.1 | 0.4 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.1 | 0.1 | GO:0070459 | prolactin secretion(GO:0070459) |
0.1 | 0.4 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.1 | 0.6 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.1 | 0.3 | GO:0001759 | organ induction(GO:0001759) |
0.1 | 0.4 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
0.1 | 0.4 | GO:0097320 | membrane tubulation(GO:0097320) |
0.1 | 0.3 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.1 | 0.3 | GO:0051985 | negative regulation of chromosome segregation(GO:0051985) |
0.1 | 0.6 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
0.1 | 9.5 | GO:0071230 | cellular response to amino acid stimulus(GO:0071230) |
0.1 | 0.2 | GO:0070542 | response to fatty acid(GO:0070542) |
0.1 | 0.2 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.1 | 0.2 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.1 | 0.2 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.1 | 0.6 | GO:0042130 | negative regulation of T cell proliferation(GO:0042130) |
0.1 | 0.2 | GO:0009070 | serine family amino acid biosynthetic process(GO:0009070) |
0.1 | 0.3 | GO:0043535 | regulation of blood vessel endothelial cell migration(GO:0043535) |
0.1 | 0.1 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.1 | 0.3 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.1 | 0.3 | GO:0035590 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.1 | 0.3 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.1 | 0.2 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.1 | 0.1 | GO:0070900 | tRNA wobble uridine modification(GO:0002098) mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.1 | 0.1 | GO:0001961 | positive regulation of cytokine-mediated signaling pathway(GO:0001961) |
0.1 | 0.4 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.1 | 1.9 | GO:0006476 | protein deacetylation(GO:0006476) |
0.1 | 0.4 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.1 | 0.5 | GO:0007099 | centriole replication(GO:0007099) |
0.1 | 0.1 | GO:0019585 | uronic acid metabolic process(GO:0006063) glucuronate metabolic process(GO:0019585) |
0.1 | 21.1 | GO:0007283 | spermatogenesis(GO:0007283) |
0.1 | 0.7 | GO:0032873 | negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
0.1 | 0.3 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.1 | 0.4 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.1 | 1.9 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.1 | 0.3 | GO:0036260 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.1 | 0.6 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.1 | 0.4 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.1 | 1.1 | GO:0042733 | embryonic digit morphogenesis(GO:0042733) |
0.1 | 0.3 | GO:0072348 | sulfur compound transport(GO:0072348) |
0.1 | 0.1 | GO:0032278 | positive regulation of gonadotropin secretion(GO:0032278) |
0.1 | 0.2 | GO:0002664 | regulation of T cell tolerance induction(GO:0002664) |
0.1 | 0.1 | GO:0007350 | blastoderm segmentation(GO:0007350) tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.1 | 0.1 | GO:0015791 | polyol transport(GO:0015791) |
0.1 | 0.1 | GO:0050779 | RNA destabilization(GO:0050779) |
0.1 | 0.1 | GO:0060099 | regulation of phagocytosis, engulfment(GO:0060099) |
0.1 | 0.1 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.1 | 0.1 | GO:0043369 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment(GO:0043369) |
0.1 | 0.1 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
0.1 | 1.6 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.1 | 0.2 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.1 | 0.3 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
0.1 | 0.9 | GO:0019835 | cytolysis(GO:0019835) |
0.1 | 0.3 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.1 | 1.4 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.1 | 0.6 | GO:0001570 | vasculogenesis(GO:0001570) |
0.1 | 0.2 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.1 | 0.1 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.1 | 0.1 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.1 | 0.7 | GO:1901998 | toxin transport(GO:1901998) |
0.1 | 0.1 | GO:0070192 | chromosome organization involved in meiotic cell cycle(GO:0070192) |
0.1 | 0.1 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.1 | 0.4 | GO:0035082 | axoneme assembly(GO:0035082) |
0.1 | 0.1 | GO:0032814 | regulation of natural killer cell activation(GO:0032814) |
0.1 | 0.1 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.1 | 0.2 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 0.8 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.1 | 0.1 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.1 | 0.2 | GO:1903232 | melanosome assembly(GO:1903232) |
0.1 | 0.7 | GO:0007051 | spindle organization(GO:0007051) |
0.1 | 0.2 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.1 | 0.3 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.1 | 0.1 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.0 | 0.1 | GO:0001835 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.0 | 0.1 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.0 | 2.1 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.0 | 1.4 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.0 | 0.1 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.0 | 0.1 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
0.0 | 44.8 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.0 | 0.0 | GO:0032682 | negative regulation of chemokine production(GO:0032682) |
0.0 | 0.0 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.0 | 0.1 | GO:0051298 | centrosome duplication(GO:0051298) |
0.0 | 0.1 | GO:0070269 | pyroptosis(GO:0070269) |
0.0 | 0.1 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.0 | 0.1 | GO:0050907 | detection of chemical stimulus involved in sensory perception(GO:0050907) |
0.0 | 0.0 | GO:0002714 | positive regulation of B cell mediated immunity(GO:0002714) positive regulation of immunoglobulin mediated immune response(GO:0002891) |
0.0 | 1.2 | GO:0007059 | chromosome segregation(GO:0007059) |
0.0 | 1.4 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
0.0 | 0.3 | GO:0051438 | regulation of ubiquitin-protein transferase activity(GO:0051438) |
0.0 | 0.1 | GO:0031935 | regulation of chromatin silencing(GO:0031935) |
0.0 | 0.3 | GO:0002902 | regulation of B cell apoptotic process(GO:0002902) |
0.0 | 0.1 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.0 | 0.1 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.0 | 0.8 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.0 | 0.0 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.0 | 0.0 | GO:0035313 | wound healing, spreading of epidermal cells(GO:0035313) |
0.0 | 0.6 | GO:0016042 | lipid catabolic process(GO:0016042) |
0.0 | 0.0 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.0 | 0.1 | GO:0045576 | mast cell activation(GO:0045576) |
0.0 | 0.2 | GO:0000209 | protein polyubiquitination(GO:0000209) |
0.0 | 0.1 | GO:0006109 | regulation of carbohydrate metabolic process(GO:0006109) |
0.0 | 0.0 | GO:0006013 | mannose metabolic process(GO:0006013) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.9 | 24.3 | GO:0031094 | platelet dense tubular network(GO:0031094) |
4.6 | 23.2 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
4.5 | 13.6 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
4.4 | 8.8 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
4.3 | 21.5 | GO:0005638 | lamin filament(GO:0005638) |
4.2 | 16.9 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
4.2 | 12.6 | GO:0097413 | Lewy body(GO:0097413) |
4.0 | 20.1 | GO:0016461 | unconventional myosin complex(GO:0016461) |
4.0 | 19.8 | GO:0008091 | spectrin(GO:0008091) |
3.9 | 11.6 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
3.8 | 11.4 | GO:0097513 | myosin II filament(GO:0097513) |
3.7 | 30.0 | GO:0030056 | hemidesmosome(GO:0030056) |
3.7 | 14.6 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
3.5 | 24.7 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
3.5 | 10.5 | GO:0005833 | hemoglobin complex(GO:0005833) |
3.4 | 10.1 | GO:0005610 | laminin-5 complex(GO:0005610) |
3.4 | 10.1 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
3.3 | 9.9 | GO:0097443 | sorting endosome(GO:0097443) |
3.3 | 6.5 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
3.0 | 12.1 | GO:0071141 | SMAD protein complex(GO:0071141) |
3.0 | 23.7 | GO:0005861 | troponin complex(GO:0005861) |
2.9 | 17.3 | GO:0098645 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
2.8 | 25.3 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
2.8 | 16.6 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
2.8 | 8.3 | GO:0097512 | cardiac myofibril(GO:0097512) |
2.7 | 30.2 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
2.7 | 19.0 | GO:0090543 | Flemming body(GO:0090543) |
2.7 | 13.3 | GO:0033093 | Weibel-Palade body(GO:0033093) |
2.7 | 10.6 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
2.6 | 7.7 | GO:0005642 | annulate lamellae(GO:0005642) |
2.6 | 20.5 | GO:0016600 | flotillin complex(GO:0016600) |
2.5 | 29.8 | GO:0031528 | microvillus membrane(GO:0031528) |
2.4 | 7.3 | GO:0031523 | Myb complex(GO:0031523) |
2.4 | 4.8 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
2.4 | 7.1 | GO:0032127 | dense core granule membrane(GO:0032127) |
2.3 | 25.7 | GO:0002102 | podosome(GO:0002102) |
2.3 | 2.3 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
2.3 | 11.6 | GO:1990462 | omegasome(GO:1990462) |
2.3 | 41.6 | GO:0043034 | costamere(GO:0043034) |
2.3 | 9.1 | GO:0071203 | WASH complex(GO:0071203) |
2.3 | 6.8 | GO:0005588 | collagen type V trimer(GO:0005588) |
2.3 | 6.8 | GO:1990204 | oxidoreductase complex(GO:1990204) |
2.2 | 11.2 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
2.2 | 13.4 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
2.2 | 35.7 | GO:0000421 | autophagosome membrane(GO:0000421) |
2.2 | 8.7 | GO:0033269 | internode region of axon(GO:0033269) |
2.2 | 8.7 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
2.2 | 4.3 | GO:0005914 | spot adherens junction(GO:0005914) |
2.1 | 6.3 | GO:0035189 | Rb-E2F complex(GO:0035189) |
2.1 | 8.4 | GO:0005927 | muscle tendon junction(GO:0005927) |
2.1 | 23.1 | GO:0031430 | M band(GO:0031430) |
2.1 | 10.5 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
2.1 | 6.2 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
2.0 | 105.1 | GO:0032432 | actin filament bundle(GO:0032432) |
2.0 | 13.8 | GO:0000788 | nuclear nucleosome(GO:0000788) |
2.0 | 17.7 | GO:0042641 | actomyosin(GO:0042641) |
2.0 | 3.9 | GO:0097524 | sperm plasma membrane(GO:0097524) |
1.9 | 5.8 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
1.9 | 15.0 | GO:0042627 | chylomicron(GO:0042627) |
1.9 | 7.5 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
1.9 | 14.9 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
1.9 | 5.6 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
1.8 | 5.5 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
1.8 | 10.9 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
1.8 | 7.0 | GO:0072487 | MSL complex(GO:0072487) |
1.7 | 7.0 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
1.7 | 12.2 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
1.7 | 5.2 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
1.7 | 8.7 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
1.7 | 6.8 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
1.7 | 15.3 | GO:0097539 | ciliary transition fiber(GO:0097539) |
1.7 | 10.1 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
1.7 | 3.4 | GO:0043259 | laminin-10 complex(GO:0043259) |
1.6 | 71.9 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
1.6 | 6.5 | GO:0042583 | chromaffin granule(GO:0042583) |
1.6 | 3.2 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
1.6 | 41.1 | GO:0055038 | recycling endosome membrane(GO:0055038) |
1.6 | 29.7 | GO:0000242 | pericentriolar material(GO:0000242) |
1.6 | 20.2 | GO:0036038 | MKS complex(GO:0036038) |
1.5 | 4.6 | GO:0097149 | centralspindlin complex(GO:0097149) |
1.5 | 13.7 | GO:0097208 | alveolar lamellar body(GO:0097208) |
1.5 | 3.0 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
1.5 | 4.6 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
1.5 | 3.0 | GO:0070820 | tertiary granule(GO:0070820) |
1.5 | 7.6 | GO:0001651 | dense fibrillar component(GO:0001651) |
1.5 | 4.5 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
1.5 | 7.5 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
1.5 | 7.5 | GO:0044294 | dendritic growth cone(GO:0044294) |
1.5 | 6.0 | GO:0097470 | ribbon synapse(GO:0097470) |
1.5 | 10.5 | GO:0031931 | TORC1 complex(GO:0031931) |
1.5 | 3.0 | GO:0005683 | U7 snRNP(GO:0005683) |
1.5 | 4.5 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
1.5 | 8.7 | GO:0038201 | TOR complex(GO:0038201) |
1.4 | 28.4 | GO:0008305 | integrin complex(GO:0008305) |
1.4 | 5.6 | GO:0005827 | polar microtubule(GO:0005827) |
1.4 | 1.4 | GO:0036449 | microtubule minus-end(GO:0036449) |
1.4 | 2.8 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
1.4 | 5.6 | GO:0071953 | elastic fiber(GO:0071953) |
1.4 | 11.1 | GO:0000815 | ESCRT III complex(GO:0000815) |
1.4 | 1.4 | GO:0044327 | dendritic spine head(GO:0044327) |
1.4 | 56.2 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
1.4 | 1.4 | GO:0010369 | chromocenter(GO:0010369) |
1.4 | 4.1 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
1.4 | 17.6 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
1.4 | 1.4 | GO:1990716 | axonemal central apparatus(GO:1990716) |
1.3 | 13.5 | GO:0031010 | ISWI-type complex(GO:0031010) |
1.3 | 10.8 | GO:0044666 | MLL3/4 complex(GO:0044666) |
1.3 | 1.3 | GO:0032133 | chromosome passenger complex(GO:0032133) |
1.3 | 4.0 | GO:1990423 | RZZ complex(GO:1990423) |
1.3 | 9.3 | GO:0045179 | apical cortex(GO:0045179) |
1.3 | 1.3 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
1.3 | 6.6 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
1.3 | 6.6 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
1.3 | 19.7 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
1.3 | 3.9 | GO:0070938 | contractile ring(GO:0070938) |
1.3 | 10.4 | GO:0042587 | glycogen granule(GO:0042587) |
1.3 | 19.3 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
1.3 | 7.7 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
1.3 | 7.7 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
1.3 | 12.7 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
1.3 | 5.1 | GO:0071439 | clathrin complex(GO:0071439) |
1.3 | 12.7 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
1.3 | 5.0 | GO:1990130 | Iml1 complex(GO:1990130) |
1.2 | 8.7 | GO:0005677 | chromatin silencing complex(GO:0005677) |
1.2 | 2.4 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
1.2 | 51.4 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
1.2 | 8.4 | GO:0098576 | lumenal side of membrane(GO:0098576) |
1.2 | 9.6 | GO:0031143 | pseudopodium(GO:0031143) |
1.2 | 2.4 | GO:0044462 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
1.2 | 1.2 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
1.2 | 3.6 | GO:0097452 | GAIT complex(GO:0097452) |
1.2 | 68.7 | GO:0000118 | histone deacetylase complex(GO:0000118) |
1.2 | 11.8 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
1.2 | 2.4 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
1.2 | 3.5 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
1.2 | 3.5 | GO:0005828 | kinetochore microtubule(GO:0005828) |
1.2 | 2.3 | GO:0031262 | Ndc80 complex(GO:0031262) |
1.2 | 4.7 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
1.2 | 6.9 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
1.1 | 4.6 | GO:0000938 | GARP complex(GO:0000938) |
1.1 | 3.4 | GO:1990923 | PET complex(GO:1990923) |
1.1 | 5.7 | GO:0070688 | MLL5-L complex(GO:0070688) |
1.1 | 12.5 | GO:0042589 | zymogen granule membrane(GO:0042589) |
1.1 | 14.7 | GO:0005865 | striated muscle thin filament(GO:0005865) |
1.1 | 31.6 | GO:0009925 | basal plasma membrane(GO:0009925) |
1.1 | 1.1 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
1.1 | 20.1 | GO:0045120 | pronucleus(GO:0045120) |
1.1 | 3.3 | GO:0046691 | intracellular canaliculus(GO:0046691) |
1.1 | 23.2 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
1.1 | 8.8 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
1.1 | 2.2 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
1.1 | 7.6 | GO:0042382 | paraspeckles(GO:0042382) |
1.1 | 3.3 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
1.1 | 10.8 | GO:0097431 | mitotic spindle pole(GO:0097431) |
1.1 | 17.3 | GO:0005844 | polysome(GO:0005844) |
1.1 | 5.4 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
1.1 | 4.3 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
1.1 | 4.3 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
1.1 | 15.0 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
1.1 | 1.1 | GO:0005879 | axonemal microtubule(GO:0005879) |
1.1 | 10.6 | GO:0046581 | intercellular canaliculus(GO:0046581) |
1.1 | 3.2 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
1.1 | 34.8 | GO:0016592 | mediator complex(GO:0016592) |
1.1 | 4.2 | GO:0001650 | fibrillar center(GO:0001650) |
1.0 | 2.1 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
1.0 | 3.1 | GO:0042612 | MHC class I protein complex(GO:0042612) |
1.0 | 93.5 | GO:0005903 | brush border(GO:0005903) |
1.0 | 58.2 | GO:0016605 | PML body(GO:0016605) |
1.0 | 2.1 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
1.0 | 14.4 | GO:0000974 | Prp19 complex(GO:0000974) |
1.0 | 52.4 | GO:0005811 | lipid particle(GO:0005811) |
1.0 | 3.1 | GO:0005745 | m-AAA complex(GO:0005745) |
1.0 | 6.1 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
1.0 | 3.0 | GO:0044194 | cytolytic granule(GO:0044194) |
1.0 | 2.0 | GO:0016939 | kinesin II complex(GO:0016939) |
1.0 | 9.0 | GO:0030139 | endocytic vesicle(GO:0030139) |
1.0 | 1.0 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
1.0 | 4.0 | GO:0031970 | organelle envelope lumen(GO:0031970) |
1.0 | 4.0 | GO:0035861 | site of double-strand break(GO:0035861) |
1.0 | 1.0 | GO:0000439 | core TFIIH complex(GO:0000439) |
1.0 | 12.8 | GO:0016459 | myosin complex(GO:0016459) |
1.0 | 2.0 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
1.0 | 4.8 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
1.0 | 1.9 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
1.0 | 2.9 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
1.0 | 2.9 | GO:0000811 | GINS complex(GO:0000811) |
1.0 | 3.9 | GO:0042825 | TAP complex(GO:0042825) |
1.0 | 6.7 | GO:0032591 | dendritic spine membrane(GO:0032591) |
1.0 | 1.9 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
1.0 | 4.8 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
1.0 | 1.0 | GO:0001652 | granular component(GO:0001652) |
0.9 | 35.0 | GO:0045095 | keratin filament(GO:0045095) |
0.9 | 8.5 | GO:0043196 | varicosity(GO:0043196) |
0.9 | 66.9 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.9 | 2.8 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.9 | 239.5 | GO:0005925 | cell-substrate adherens junction(GO:0005924) focal adhesion(GO:0005925) cell-substrate junction(GO:0030055) |
0.9 | 11.1 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
0.9 | 0.9 | GO:0005686 | U2 snRNP(GO:0005686) |
0.9 | 0.9 | GO:0034464 | BBSome(GO:0034464) |
0.9 | 14.6 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.9 | 4.5 | GO:0034709 | methylosome(GO:0034709) |
0.9 | 2.7 | GO:0005795 | Golgi stack(GO:0005795) |
0.9 | 4.5 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.9 | 10.7 | GO:0005682 | U5 snRNP(GO:0005682) |
0.9 | 5.3 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.9 | 3.5 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.9 | 0.9 | GO:0000346 | transcription export complex(GO:0000346) |
0.9 | 0.9 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.9 | 0.9 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.9 | 10.4 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.9 | 2.6 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.9 | 9.5 | GO:0035102 | PRC1 complex(GO:0035102) |
0.9 | 13.8 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.9 | 9.5 | GO:0031672 | A band(GO:0031672) |
0.9 | 1.7 | GO:0030870 | Mre11 complex(GO:0030870) |
0.9 | 11.1 | GO:0005657 | replication fork(GO:0005657) |
0.9 | 6.0 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.9 | 5.1 | GO:0031209 | SCAR complex(GO:0031209) |
0.8 | 12.7 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.8 | 0.8 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.8 | 6.7 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.8 | 1.7 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.8 | 27.7 | GO:0045171 | intercellular bridge(GO:0045171) |
0.8 | 7.5 | GO:0070852 | cell body fiber(GO:0070852) |
0.8 | 6.7 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.8 | 5.8 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.8 | 7.5 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.8 | 9.0 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.8 | 6.5 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.8 | 2.4 | GO:0005712 | chiasma(GO:0005712) |
0.8 | 1.6 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.8 | 0.8 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.8 | 4.8 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.8 | 4.8 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.8 | 4.0 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.8 | 0.8 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.8 | 26.7 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.8 | 1.6 | GO:0005955 | calcineurin complex(GO:0005955) |
0.8 | 1.6 | GO:0045180 | basal cortex(GO:0045180) |
0.8 | 6.2 | GO:0001891 | phagocytic cup(GO:0001891) |
0.8 | 6.2 | GO:0046930 | pore complex(GO:0046930) |
0.8 | 20.9 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.8 | 22.3 | GO:0005776 | autophagosome(GO:0005776) |
0.8 | 2.3 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.8 | 6.9 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.8 | 6.1 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.8 | 14.4 | GO:0000791 | euchromatin(GO:0000791) |
0.8 | 2.3 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.8 | 31.6 | GO:0016363 | nuclear matrix(GO:0016363) |
0.8 | 0.8 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.7 | 3.7 | GO:0005652 | nuclear lamina(GO:0005652) |
0.7 | 9.7 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.7 | 3.0 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.7 | 5.9 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.7 | 0.7 | GO:0044299 | C-fiber(GO:0044299) |
0.7 | 0.7 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.7 | 5.2 | GO:0042588 | zymogen granule(GO:0042588) |
0.7 | 27.2 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
0.7 | 6.6 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.7 | 24.8 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.7 | 1.4 | GO:1990246 | uniplex complex(GO:1990246) |
0.7 | 2.2 | GO:0005915 | zonula adherens(GO:0005915) |
0.7 | 2.9 | GO:0097542 | ciliary tip(GO:0097542) |
0.7 | 3.6 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.7 | 2.1 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.7 | 5.7 | GO:0070652 | HAUS complex(GO:0070652) |
0.7 | 57.1 | GO:0000793 | condensed chromosome(GO:0000793) |
0.7 | 16.8 | GO:0031901 | early endosome membrane(GO:0031901) |
0.7 | 11.9 | GO:0001772 | immunological synapse(GO:0001772) |
0.7 | 2.8 | GO:0005774 | vacuolar membrane(GO:0005774) |
0.7 | 4.9 | GO:0031512 | motile primary cilium(GO:0031512) |
0.7 | 48.8 | GO:0072562 | blood microparticle(GO:0072562) |
0.7 | 15.1 | GO:0015030 | Cajal body(GO:0015030) |
0.7 | 7.5 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.7 | 2.0 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.7 | 1.4 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.7 | 1.4 | GO:0000322 | storage vacuole(GO:0000322) |
0.7 | 2.0 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.7 | 10.2 | GO:0044448 | cell cortex part(GO:0044448) |
0.7 | 12.2 | GO:0005922 | connexon complex(GO:0005922) |
0.7 | 4.7 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.7 | 20.8 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.7 | 13.3 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.7 | 4.0 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.7 | 2.6 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.7 | 1.3 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.6 | 1.3 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.6 | 45.2 | GO:0005581 | collagen trimer(GO:0005581) |
0.6 | 35.3 | GO:0010008 | endosome membrane(GO:0010008) |
0.6 | 1.3 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.6 | 1.9 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.6 | 1.9 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.6 | 3.2 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.6 | 2.5 | GO:0000812 | Swr1 complex(GO:0000812) |
0.6 | 27.1 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.6 | 0.6 | GO:0030904 | retromer complex(GO:0030904) |
0.6 | 5.0 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.6 | 2.5 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.6 | 2.5 | GO:0043203 | axon hillock(GO:0043203) |
0.6 | 5.5 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.6 | 61.6 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.6 | 4.2 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.6 | 6.7 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.6 | 1.2 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.6 | 0.6 | GO:0002139 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) USH2 complex(GO:1990696) |
0.6 | 0.6 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.6 | 4.7 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.6 | 2.4 | GO:0005916 | fascia adherens(GO:0005916) |
0.6 | 5.3 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.6 | 3.5 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.6 | 1.2 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.6 | 1.7 | GO:0043293 | apoptosome(GO:0043293) |
0.6 | 5.8 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.6 | 1.2 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.6 | 1.7 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.6 | 0.6 | GO:0097422 | tubular endosome(GO:0097422) |
0.6 | 1.1 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.6 | 4.4 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.5 | 1.1 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.5 | 1.6 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.5 | 106.5 | GO:0005667 | transcription factor complex(GO:0005667) |
0.5 | 6.5 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.5 | 3.8 | GO:1990391 | DNA repair complex(GO:1990391) |
0.5 | 1.1 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.5 | 7.4 | GO:0031519 | PcG protein complex(GO:0031519) |
0.5 | 9.5 | GO:0032587 | ruffle membrane(GO:0032587) |
0.5 | 146.2 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.5 | 4.7 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.5 | 4.7 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.5 | 6.7 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.5 | 1.0 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.5 | 2.5 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.5 | 12.0 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.5 | 1.5 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.5 | 3.0 | GO:0016272 | prefoldin complex(GO:0016272) |
0.5 | 0.5 | GO:0019814 | immunoglobulin complex(GO:0019814) |
0.5 | 1.0 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.5 | 0.5 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.5 | 19.7 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.5 | 1.4 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.5 | 5.7 | GO:0000502 | proteasome complex(GO:0000502) |
0.5 | 1.4 | GO:0022624 | proteasome regulatory particle(GO:0005838) proteasome accessory complex(GO:0022624) |
0.5 | 9.3 | GO:0005643 | nuclear pore(GO:0005643) |
0.5 | 14.4 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.5 | 21.8 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.5 | 2.3 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.5 | 1.8 | GO:0042599 | lamellar body(GO:0042599) |
0.4 | 508.7 | GO:0005654 | nucleoplasm(GO:0005654) |
0.4 | 8.5 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.4 | 0.9 | GO:0098536 | deuterosome(GO:0098536) |
0.4 | 0.9 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.4 | 8.0 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.4 | 2.6 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.4 | 0.9 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.4 | 4.4 | GO:0000786 | nucleosome(GO:0000786) |
0.4 | 1.3 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.4 | 0.9 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.4 | 5.1 | GO:0043205 | fibril(GO:0043205) |
0.4 | 0.8 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.4 | 2.5 | GO:0030008 | TRAPP complex(GO:0030008) |
0.4 | 109.4 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.4 | 1.7 | GO:0090544 | BAF-type complex(GO:0090544) |
0.4 | 11.3 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
0.4 | 0.8 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.4 | 5.4 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.4 | 1.2 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.4 | 11.2 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.4 | 4.9 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.4 | 0.8 | GO:0036128 | CatSper complex(GO:0036128) |
0.4 | 2.4 | GO:0097225 | sperm midpiece(GO:0097225) |
0.4 | 9.4 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.4 | 21.9 | GO:0005882 | intermediate filament(GO:0005882) |
0.4 | 50.0 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.4 | 1.6 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.4 | 4.3 | GO:0005771 | multivesicular body(GO:0005771) |
0.4 | 3.9 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.4 | 0.4 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.4 | 0.4 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.4 | 0.4 | GO:0097525 | spliceosomal snRNP complex(GO:0097525) |
0.4 | 2.6 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.4 | 20.4 | GO:0000228 | nuclear chromosome(GO:0000228) |
0.4 | 2.2 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.4 | 8.8 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.4 | 1.8 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.4 | 2.5 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.4 | 468.4 | GO:0070062 | extracellular exosome(GO:0070062) |
0.4 | 5.4 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.3 | 0.7 | GO:0005605 | basal lamina(GO:0005605) |
0.3 | 8.0 | GO:0005938 | cell cortex(GO:0005938) |
0.3 | 1.3 | GO:0035339 | SPOTS complex(GO:0035339) |
0.3 | 0.7 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.3 | 0.6 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.3 | 1.3 | GO:0061702 | inflammasome complex(GO:0061702) |
0.3 | 3.8 | GO:0005614 | interstitial matrix(GO:0005614) |
0.3 | 1.2 | GO:0031211 | palmitoyltransferase complex(GO:0002178) serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.3 | 2.5 | GO:0032426 | stereocilium tip(GO:0032426) |
0.3 | 1.5 | GO:0005901 | caveola(GO:0005901) |
0.3 | 5.2 | GO:0032040 | small-subunit processome(GO:0032040) |
0.3 | 1.2 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.3 | 3.9 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.3 | 16.9 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.3 | 0.3 | GO:0042175 | nuclear outer membrane-endoplasmic reticulum membrane network(GO:0042175) |
0.3 | 192.3 | GO:0005739 | mitochondrion(GO:0005739) |
0.3 | 1.1 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.3 | 2.3 | GO:0036157 | outer dynein arm(GO:0036157) |
0.3 | 0.8 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.3 | 119.7 | GO:0005829 | cytosol(GO:0005829) |
0.3 | 0.3 | GO:1902493 | protein acetyltransferase complex(GO:0031248) acetyltransferase complex(GO:1902493) |
0.2 | 47.1 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.2 | 0.5 | GO:0072687 | meiotic spindle(GO:0072687) |
0.2 | 22.7 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.2 | 0.2 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.2 | 0.7 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.2 | 4.6 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.2 | 0.4 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.2 | 0.4 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.2 | 0.8 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.2 | 6.6 | GO:0000139 | Golgi membrane(GO:0000139) |
0.2 | 0.8 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.2 | 3.2 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.2 | 1.2 | GO:0060170 | ciliary membrane(GO:0060170) |
0.2 | 0.2 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.2 | 7.7 | GO:0001533 | cornified envelope(GO:0001533) |
0.2 | 0.2 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.2 | 4.6 | GO:0043292 | contractile fiber(GO:0043292) |
0.2 | 0.2 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.2 | 0.7 | GO:0043218 | compact myelin(GO:0043218) |
0.2 | 0.9 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.2 | 1.4 | GO:0031231 | intrinsic component of peroxisomal membrane(GO:0031231) |
0.2 | 0.2 | GO:0030880 | RNA polymerase complex(GO:0030880) |
0.2 | 0.5 | GO:0044292 | dendrite terminus(GO:0044292) |
0.2 | 0.2 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.2 | 0.2 | GO:0097546 | ciliary base(GO:0097546) |
0.2 | 0.3 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.2 | 0.5 | GO:0097440 | apical dendrite(GO:0097440) |
0.2 | 0.6 | GO:0001741 | XY body(GO:0001741) |
0.2 | 19.6 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.2 | 0.5 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 86.7 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.1 | 4.5 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 2.0 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 1.3 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.1 | 0.7 | GO:0005876 | spindle microtubule(GO:0005876) |
0.1 | 4.0 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.1 | 0.6 | GO:0034399 | nuclear periphery(GO:0034399) |
0.1 | 0.1 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.1 | 57.9 | GO:0005615 | extracellular space(GO:0005615) |
0.1 | 0.1 | GO:0030990 | intraciliary transport particle(GO:0030990) intraciliary transport particle A(GO:0030991) |
0.1 | 16.1 | GO:0070013 | intracellular organelle lumen(GO:0070013) |
0.1 | 0.1 | GO:0035838 | growing cell tip(GO:0035838) |
0.1 | 0.2 | GO:0001520 | outer dense fiber(GO:0001520) |
0.1 | 0.5 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.1 | 0.1 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 0.7 | GO:0097223 | sperm part(GO:0097223) |
0.1 | 32.6 | GO:0005576 | extracellular region(GO:0005576) |
0.0 | 0.9 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.0 | 1.4 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 0.1 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.0 | 45.5 | GO:0005634 | nucleus(GO:0005634) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.5 | 22.6 | GO:0070644 | vitamin D response element binding(GO:0070644) |
5.8 | 17.5 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
5.6 | 22.6 | GO:0019158 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
5.5 | 21.9 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
5.2 | 15.7 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
5.1 | 15.4 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
5.0 | 20.2 | GO:0031720 | haptoglobin binding(GO:0031720) |
5.0 | 5.0 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
4.8 | 14.3 | GO:0005350 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
4.7 | 32.9 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
4.6 | 13.9 | GO:0031005 | filamin binding(GO:0031005) |
4.4 | 13.2 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
4.3 | 4.3 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
4.1 | 29.0 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
4.1 | 24.3 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
4.0 | 12.0 | GO:0048030 | disaccharide binding(GO:0048030) |
4.0 | 12.0 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
3.9 | 11.8 | GO:0030172 | troponin C binding(GO:0030172) |
3.9 | 31.0 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
3.8 | 15.4 | GO:0042731 | PH domain binding(GO:0042731) |
3.8 | 7.6 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
3.7 | 11.2 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
3.7 | 14.7 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
3.6 | 42.7 | GO:0044548 | S100 protein binding(GO:0044548) |
3.5 | 10.4 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
3.4 | 27.3 | GO:0008430 | selenium binding(GO:0008430) |
3.4 | 10.2 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
3.4 | 16.8 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
3.4 | 13.4 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
3.3 | 16.6 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
3.3 | 6.6 | GO:0016842 | amidine-lyase activity(GO:0016842) |
3.3 | 6.5 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
3.2 | 16.2 | GO:0016936 | galactoside binding(GO:0016936) |
3.2 | 9.7 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
3.2 | 12.7 | GO:1990715 | mRNA CDS binding(GO:1990715) |
3.2 | 9.5 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
3.1 | 12.5 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
3.1 | 15.5 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
3.1 | 34.0 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
3.1 | 9.2 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
3.1 | 12.2 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
3.0 | 3.0 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
3.0 | 6.0 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
3.0 | 11.9 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
3.0 | 8.9 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
2.9 | 11.8 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
2.9 | 20.6 | GO:0018639 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
2.9 | 20.6 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
2.9 | 8.8 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
2.9 | 14.4 | GO:0051525 | NFAT protein binding(GO:0051525) |
2.9 | 14.3 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
2.8 | 8.5 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
2.7 | 10.9 | GO:0015057 | thrombin receptor activity(GO:0015057) |
2.7 | 8.2 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
2.7 | 8.1 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
2.7 | 5.4 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
2.7 | 2.7 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
2.7 | 8.1 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
2.7 | 29.4 | GO:0017166 | vinculin binding(GO:0017166) |
2.7 | 18.7 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
2.7 | 10.7 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
2.7 | 10.6 | GO:0005344 | oxygen transporter activity(GO:0005344) |
2.6 | 5.3 | GO:0038181 | bile acid receptor activity(GO:0038181) |
2.6 | 34.3 | GO:0008307 | structural constituent of muscle(GO:0008307) |
2.6 | 2.6 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
2.6 | 10.4 | GO:0051434 | BH3 domain binding(GO:0051434) |
2.6 | 2.6 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
2.6 | 10.3 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
2.6 | 10.3 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
2.6 | 28.2 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
2.6 | 10.2 | GO:0004046 | aminoacylase activity(GO:0004046) |
2.5 | 5.1 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
2.5 | 2.5 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
2.5 | 7.5 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
2.5 | 5.0 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
2.5 | 2.5 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
2.5 | 19.8 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
2.5 | 2.5 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
2.4 | 2.4 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
2.4 | 19.5 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
2.4 | 2.4 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
2.4 | 4.8 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
2.4 | 7.2 | GO:0061513 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
2.4 | 11.9 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
2.4 | 14.3 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
2.4 | 23.7 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
2.3 | 7.0 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
2.3 | 7.0 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
2.3 | 9.3 | GO:0009374 | biotin binding(GO:0009374) |
2.3 | 13.8 | GO:0038132 | neuregulin binding(GO:0038132) |
2.3 | 9.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
2.3 | 27.2 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
2.2 | 29.1 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
2.2 | 6.7 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
2.2 | 17.7 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
2.2 | 13.3 | GO:0001727 | lipid kinase activity(GO:0001727) |
2.2 | 4.4 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
2.2 | 6.6 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
2.2 | 19.6 | GO:0008432 | JUN kinase binding(GO:0008432) |
2.2 | 6.5 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
2.2 | 17.2 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
2.1 | 12.8 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
2.1 | 38.4 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
2.1 | 8.5 | GO:0047105 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
2.1 | 10.6 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
2.1 | 25.3 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
2.1 | 14.7 | GO:0019966 | interleukin-1 binding(GO:0019966) |
2.1 | 8.4 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
2.1 | 16.8 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
2.1 | 2.1 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
2.1 | 8.3 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
2.1 | 8.2 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
2.1 | 6.2 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
2.0 | 6.1 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
2.0 | 18.2 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
2.0 | 6.1 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
2.0 | 2.0 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
2.0 | 30.1 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
2.0 | 10.0 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
2.0 | 6.0 | GO:0043199 | sulfate binding(GO:0043199) |
2.0 | 10.0 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
2.0 | 9.9 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
2.0 | 7.9 | GO:0052795 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
2.0 | 6.0 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
2.0 | 9.9 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
2.0 | 9.8 | GO:0042015 | interleukin-20 binding(GO:0042015) |
1.9 | 7.8 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
1.9 | 5.8 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
1.9 | 15.4 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
1.9 | 7.7 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
1.9 | 7.7 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
1.9 | 7.6 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
1.9 | 5.7 | GO:1990460 | leptin receptor binding(GO:1990460) |
1.9 | 17.1 | GO:0030983 | mismatched DNA binding(GO:0030983) |
1.9 | 1.9 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
1.9 | 3.8 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
1.9 | 11.1 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
1.9 | 5.6 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
1.9 | 18.5 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
1.8 | 5.5 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
1.8 | 5.5 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
1.8 | 12.7 | GO:0019957 | C-C chemokine binding(GO:0019957) |
1.8 | 7.2 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
1.8 | 1.8 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
1.8 | 7.2 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
1.8 | 5.4 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
1.8 | 17.8 | GO:0050308 | sugar-phosphatase activity(GO:0050308) |
1.8 | 5.3 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
1.8 | 7.1 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
1.8 | 5.3 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
1.8 | 5.3 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
1.7 | 8.7 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
1.7 | 5.2 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
1.7 | 26.0 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
1.7 | 1.7 | GO:0016531 | copper chaperone activity(GO:0016531) |
1.7 | 5.2 | GO:0019770 | IgG receptor activity(GO:0019770) |
1.7 | 1.7 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
1.7 | 1.7 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
1.7 | 10.3 | GO:0043910 | CTP:2,3-di-O-geranylgeranyl-sn-glycero-1-phosphate cytidyltransferase activity(GO:0043338) phospholactate guanylyltransferase activity(GO:0043814) ATP:coenzyme F420 adenylyltransferase activity(GO:0043910) UDP-N-acetylgalactosamine diphosphorylase activity(GO:0052630) |
1.7 | 1.7 | GO:0042834 | peptidoglycan binding(GO:0042834) |
1.7 | 6.8 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
1.7 | 1.7 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
1.7 | 5.1 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
1.7 | 5.1 | GO:0031014 | troponin T binding(GO:0031014) |
1.7 | 22.0 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
1.7 | 5.1 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
1.7 | 5.0 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
1.7 | 3.4 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
1.7 | 46.6 | GO:0001221 | transcription cofactor binding(GO:0001221) |
1.7 | 3.3 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
1.7 | 24.9 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
1.7 | 19.9 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
1.7 | 6.6 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
1.7 | 8.3 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
1.7 | 5.0 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
1.6 | 4.9 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
1.6 | 14.7 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
1.6 | 4.9 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
1.6 | 30.8 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
1.6 | 9.7 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
1.6 | 8.1 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
1.6 | 4.8 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
1.6 | 8.0 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
1.6 | 6.4 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
1.6 | 4.8 | GO:0055100 | adiponectin binding(GO:0055100) |
1.6 | 3.2 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
1.6 | 7.9 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
1.6 | 3.2 | GO:0070546 | L-phenylalanine aminotransferase activity(GO:0070546) |
1.6 | 3.2 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
1.6 | 34.5 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
1.6 | 4.7 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
1.6 | 3.1 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
1.6 | 4.7 | GO:0030350 | iron-responsive element binding(GO:0030350) |
1.6 | 3.1 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
1.6 | 12.4 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
1.5 | 13.9 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
1.5 | 4.6 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
1.5 | 10.8 | GO:0016803 | ether hydrolase activity(GO:0016803) |
1.5 | 4.6 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
1.5 | 15.2 | GO:0035497 | cAMP response element binding(GO:0035497) |
1.5 | 3.0 | GO:0071253 | connexin binding(GO:0071253) |
1.5 | 4.5 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
1.5 | 4.5 | GO:0001016 | RNA polymerase III regulatory region DNA binding(GO:0001016) |
1.5 | 25.4 | GO:0070064 | proline-rich region binding(GO:0070064) |
1.5 | 4.5 | GO:0038100 | nodal binding(GO:0038100) |
1.5 | 8.9 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
1.5 | 4.4 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
1.5 | 14.8 | GO:0003993 | acid phosphatase activity(GO:0003993) |
1.5 | 11.8 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
1.5 | 30.8 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
1.5 | 4.4 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
1.5 | 1.5 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
1.5 | 4.4 | GO:0008506 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
1.5 | 20.4 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
1.5 | 8.8 | GO:0008199 | ferric iron binding(GO:0008199) |
1.5 | 4.4 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
1.4 | 11.6 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
1.4 | 2.9 | GO:0019961 | interferon binding(GO:0019961) |
1.4 | 13.0 | GO:0015254 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
1.4 | 13.0 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
1.4 | 2.9 | GO:0004104 | cholinesterase activity(GO:0004104) |
1.4 | 4.3 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
1.4 | 8.6 | GO:0051400 | BH domain binding(GO:0051400) |
1.4 | 11.4 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
1.4 | 5.7 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
1.4 | 4.3 | GO:1990239 | steroid hormone binding(GO:1990239) |
1.4 | 5.7 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
1.4 | 18.3 | GO:0005521 | lamin binding(GO:0005521) |
1.4 | 8.4 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
1.4 | 15.4 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
1.4 | 12.5 | GO:0043995 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
1.4 | 4.2 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
1.4 | 12.4 | GO:0015643 | toxic substance binding(GO:0015643) |
1.4 | 17.9 | GO:0008143 | poly(A) binding(GO:0008143) |
1.4 | 8.2 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
1.4 | 1.4 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
1.4 | 4.1 | GO:0070061 | fructose binding(GO:0070061) |
1.4 | 8.1 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
1.4 | 4.1 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
1.4 | 6.8 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
1.4 | 24.3 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
1.3 | 9.4 | GO:0008494 | translation activator activity(GO:0008494) |
1.3 | 5.4 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
1.3 | 32.2 | GO:0043236 | laminin binding(GO:0043236) |
1.3 | 1.3 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
1.3 | 1.3 | GO:0016436 | rRNA methyltransferase activity(GO:0008649) rRNA (uridine) methyltransferase activity(GO:0016436) |
1.3 | 18.7 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
1.3 | 13.3 | GO:0070700 | BMP receptor binding(GO:0070700) |
1.3 | 4.0 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
1.3 | 18.5 | GO:0043130 | ubiquitin binding(GO:0043130) |
1.3 | 5.3 | GO:0018585 | fluorene oxygenase activity(GO:0018585) |
1.3 | 6.6 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
1.3 | 3.9 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
1.3 | 2.6 | GO:0035877 | death effector domain binding(GO:0035877) |
1.3 | 3.9 | GO:0030284 | estrogen receptor activity(GO:0030284) |
1.3 | 7.8 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
1.3 | 1.3 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
1.3 | 37.6 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
1.3 | 3.8 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
1.3 | 16.6 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
1.3 | 7.6 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
1.3 | 2.5 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
1.3 | 3.8 | GO:0070492 | oligosaccharide binding(GO:0070492) |
1.3 | 5.0 | GO:0015232 | heme transporter activity(GO:0015232) |
1.3 | 5.0 | GO:0004966 | galanin receptor activity(GO:0004966) |
1.3 | 6.3 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
1.3 | 5.0 | GO:0035671 | enone reductase activity(GO:0035671) |
1.3 | 1.3 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
1.2 | 2.5 | GO:1990188 | euchromatin binding(GO:1990188) |
1.2 | 5.0 | GO:0001849 | complement component C1q binding(GO:0001849) |
1.2 | 4.9 | GO:0005047 | signal recognition particle binding(GO:0005047) |
1.2 | 19.7 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
1.2 | 7.4 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
1.2 | 8.6 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
1.2 | 9.8 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
1.2 | 4.9 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
1.2 | 7.3 | GO:0034778 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
1.2 | 17.0 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
1.2 | 7.3 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
1.2 | 3.6 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
1.2 | 4.8 | GO:0030984 | kininogen binding(GO:0030984) |
1.2 | 12.0 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
1.2 | 8.4 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
1.2 | 2.4 | GO:0030274 | LIM domain binding(GO:0030274) |
1.2 | 1.2 | GO:0034618 | arginine binding(GO:0034618) |
1.2 | 8.3 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
1.2 | 3.6 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
1.2 | 5.9 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
1.2 | 2.4 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
1.2 | 3.5 | GO:0061665 | SUMO ligase activity(GO:0061665) |
1.2 | 13.0 | GO:0070034 | telomerase RNA binding(GO:0070034) |
1.2 | 14.1 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
1.2 | 1.2 | GO:0003696 | satellite DNA binding(GO:0003696) |
1.2 | 1.2 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
1.2 | 4.7 | GO:0001846 | opsonin binding(GO:0001846) |
1.2 | 7.0 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
1.2 | 1.2 | GO:0000405 | bubble DNA binding(GO:0000405) |
1.2 | 3.5 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
1.2 | 12.7 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
1.2 | 30.0 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
1.2 | 6.9 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
1.1 | 4.6 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
1.1 | 2.3 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
1.1 | 3.4 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
1.1 | 3.4 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
1.1 | 14.7 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
1.1 | 3.4 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
1.1 | 4.5 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
1.1 | 28.1 | GO:0008536 | Ran GTPase binding(GO:0008536) |
1.1 | 4.5 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
1.1 | 1.1 | GO:0016751 | S-succinyltransferase activity(GO:0016751) |
1.1 | 1.1 | GO:0036122 | BMP binding(GO:0036122) |
1.1 | 2.2 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
1.1 | 3.3 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
1.1 | 36.5 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
1.1 | 12.1 | GO:0001972 | retinoic acid binding(GO:0001972) |
1.1 | 11.0 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
1.1 | 1.1 | GO:0033142 | progesterone receptor binding(GO:0033142) |
1.1 | 5.5 | GO:0005113 | patched binding(GO:0005113) |
1.1 | 1.1 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
1.1 | 20.7 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
1.1 | 3.3 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
1.1 | 17.4 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
1.1 | 9.7 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
1.1 | 9.7 | GO:0031996 | thioesterase binding(GO:0031996) |
1.1 | 7.5 | GO:0005523 | tropomyosin binding(GO:0005523) |
1.1 | 2.1 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
1.1 | 2.1 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
1.1 | 4.3 | GO:0070728 | leucine binding(GO:0070728) |
1.1 | 6.4 | GO:0050733 | RS domain binding(GO:0050733) |
1.1 | 15.9 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
1.1 | 4.2 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
1.1 | 3.2 | GO:0005372 | water transmembrane transporter activity(GO:0005372) |
1.1 | 3.2 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
1.0 | 3.1 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
1.0 | 4.2 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
1.0 | 5.2 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
1.0 | 3.1 | GO:2001070 | starch binding(GO:2001070) |
1.0 | 7.2 | GO:0046790 | virion binding(GO:0046790) |
1.0 | 2.1 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
1.0 | 3.1 | GO:0051870 | methotrexate binding(GO:0051870) |
1.0 | 1.0 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
1.0 | 5.1 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
1.0 | 7.2 | GO:0048156 | tau protein binding(GO:0048156) |
1.0 | 7.1 | GO:0005542 | folic acid binding(GO:0005542) |
1.0 | 1.0 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
1.0 | 9.1 | GO:0043274 | phospholipase binding(GO:0043274) |
1.0 | 8.1 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
1.0 | 1.0 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
1.0 | 5.0 | GO:0015288 | porin activity(GO:0015288) |
1.0 | 1.0 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
1.0 | 3.0 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
1.0 | 5.9 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
1.0 | 2.0 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
1.0 | 2.0 | GO:0004771 | sterol esterase activity(GO:0004771) |
1.0 | 4.9 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
1.0 | 8.8 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) |
1.0 | 4.9 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
1.0 | 4.9 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
1.0 | 8.8 | GO:0001848 | complement binding(GO:0001848) |
1.0 | 25.3 | GO:0050699 | WW domain binding(GO:0050699) |
1.0 | 11.7 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
1.0 | 2.9 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
1.0 | 29.9 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
1.0 | 1.9 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
1.0 | 108.0 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
1.0 | 1.9 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
1.0 | 14.3 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
1.0 | 18.1 | GO:0042805 | actinin binding(GO:0042805) |
1.0 | 2.9 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.9 | 2.8 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.9 | 5.7 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.9 | 3.8 | GO:0043426 | MRF binding(GO:0043426) |
0.9 | 20.8 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.9 | 2.8 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.9 | 2.8 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.9 | 2.8 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.9 | 13.1 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.9 | 3.7 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.9 | 3.7 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.9 | 4.7 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.9 | 3.7 | GO:0031782 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.9 | 5.5 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.9 | 0.9 | GO:0070538 | oleic acid binding(GO:0070538) |
0.9 | 2.8 | GO:0030519 | snoRNP binding(GO:0030519) |
0.9 | 1.8 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.9 | 5.5 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.9 | 2.7 | GO:0000828 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.9 | 2.7 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.9 | 1.8 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.9 | 8.2 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.9 | 2.7 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.9 | 13.5 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.9 | 5.4 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.9 | 2.7 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.9 | 1.8 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.9 | 1.8 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.9 | 2.7 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.9 | 3.6 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.9 | 7.2 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.9 | 3.6 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.9 | 3.5 | GO:0043559 | insulin binding(GO:0043559) |
0.9 | 8.0 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.9 | 3.5 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.9 | 1.8 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.9 | 0.9 | GO:0016429 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
0.9 | 2.6 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.9 | 2.6 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.9 | 44.1 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.9 | 4.3 | GO:0042910 | xenobiotic transporter activity(GO:0042910) |
0.9 | 14.7 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.9 | 39.7 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.9 | 1.7 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.9 | 24.0 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.9 | 13.7 | GO:0008483 | transaminase activity(GO:0008483) |
0.9 | 6.0 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.9 | 0.9 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.9 | 4.3 | GO:0015266 | protein channel activity(GO:0015266) |
0.9 | 10.3 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.8 | 2.5 | GO:0004359 | glutaminase activity(GO:0004359) |
0.8 | 15.2 | GO:0045296 | cadherin binding(GO:0045296) |
0.8 | 0.8 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.8 | 2.5 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.8 | 17.6 | GO:0043531 | ADP binding(GO:0043531) |
0.8 | 3.3 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.8 | 2.5 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.8 | 13.4 | GO:0005112 | Notch binding(GO:0005112) |
0.8 | 8.3 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.8 | 3.3 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.8 | 19.9 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.8 | 4.1 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.8 | 5.8 | GO:0035257 | nuclear hormone receptor binding(GO:0035257) |
0.8 | 0.8 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.8 | 16.4 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.8 | 2.5 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.8 | 2.5 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.8 | 22.1 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.8 | 0.8 | GO:0051723 | protein methylesterase activity(GO:0051723) |
0.8 | 2.5 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.8 | 2.4 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.8 | 7.3 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.8 | 9.0 | GO:0010181 | FMN binding(GO:0010181) |
0.8 | 0.8 | GO:0034594 | phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
0.8 | 4.9 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.8 | 0.8 | GO:0070402 | NADPH binding(GO:0070402) |
0.8 | 17.9 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.8 | 5.7 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.8 | 3.2 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.8 | 25.1 | GO:0016830 | carbon-carbon lyase activity(GO:0016830) |
0.8 | 4.0 | GO:0005536 | glucose binding(GO:0005536) |
0.8 | 6.5 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.8 | 2.4 | GO:0034452 | dynactin binding(GO:0034452) |
0.8 | 12.8 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.8 | 11.0 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.8 | 3.9 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.8 | 18.8 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.8 | 17.2 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.8 | 4.7 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.8 | 2.3 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.8 | 5.4 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.8 | 6.1 | GO:0046977 | TAP binding(GO:0046977) |
0.8 | 2.3 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) bisphosphoglycerate 2-phosphatase activity(GO:0004083) phosphoglycerate mutase activity(GO:0004619) bisphosphoglycerate phosphatase activity(GO:0034416) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.8 | 1.5 | GO:0036033 | mediator complex binding(GO:0036033) |
0.8 | 9.8 | GO:0043139 | 5'-3' DNA helicase activity(GO:0043139) |
0.8 | 68.0 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.7 | 2.2 | GO:0098847 | single-stranded telomeric DNA binding(GO:0043047) sequence-specific single stranded DNA binding(GO:0098847) |
0.7 | 6.7 | GO:0031491 | nucleosome binding(GO:0031491) |
0.7 | 7.4 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.7 | 2.2 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.7 | 4.4 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.7 | 2.2 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.7 | 2.2 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.7 | 2.9 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.7 | 2.2 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.7 | 2.9 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.7 | 19.5 | GO:0005507 | copper ion binding(GO:0005507) |
0.7 | 1.4 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.7 | 8.7 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.7 | 1.4 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.7 | 2.2 | GO:0030911 | TPR domain binding(GO:0030911) |
0.7 | 2.2 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.7 | 2.1 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.7 | 2.1 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.7 | 3.6 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.7 | 2.1 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.7 | 1.4 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.7 | 7.0 | GO:0035173 | histone kinase activity(GO:0035173) |
0.7 | 7.0 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.7 | 2.1 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.7 | 3.5 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.7 | 27.1 | GO:0042379 | chemokine receptor binding(GO:0042379) |
0.7 | 2.8 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.7 | 2.8 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.7 | 15.9 | GO:0043738 | N-ethylmaleimide reductase activity(GO:0008748) reduced coenzyme F420 dehydrogenase activity(GO:0043738) sulfur oxygenase reductase activity(GO:0043826) malolactic enzyme activity(GO:0043883) epoxyqueuosine reductase activity(GO:0052693) |
0.7 | 4.8 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.7 | 2.1 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.7 | 1.4 | GO:0019808 | polyamine binding(GO:0019808) |
0.7 | 0.7 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.7 | 6.9 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.7 | 0.7 | GO:0034046 | poly(G) binding(GO:0034046) |
0.7 | 3.4 | GO:0050051 | leukotriene-B4 20-monooxygenase activity(GO:0050051) |
0.7 | 8.2 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.7 | 2.7 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.7 | 17.0 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.7 | 2.0 | GO:0031432 | titin binding(GO:0031432) |
0.7 | 7.4 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.7 | 2.0 | GO:0045340 | mercury ion binding(GO:0045340) |
0.7 | 2.0 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.7 | 2.0 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.7 | 2.0 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.7 | 4.7 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.7 | 2.7 | GO:0043723 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
0.7 | 5.3 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.7 | 7.3 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.7 | 29.6 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.6 | 1.9 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.6 | 1.9 | GO:0000182 | rDNA binding(GO:0000182) |
0.6 | 1.3 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.6 | 12.9 | GO:0016675 | oxidoreductase activity, acting on a heme group of donors(GO:0016675) |
0.6 | 1.3 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.6 | 4.4 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.6 | 1.3 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.6 | 1.3 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.6 | 2.5 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.6 | 3.1 | GO:0070403 | NAD+ binding(GO:0070403) |
0.6 | 7.5 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.6 | 1.3 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.6 | 5.6 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.6 | 2.5 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.6 | 16.2 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.6 | 3.1 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.6 | 1.9 | GO:0005534 | galactose binding(GO:0005534) |
0.6 | 1.2 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.6 | 3.1 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.6 | 6.1 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.6 | 3.7 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.6 | 1.8 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.6 | 3.6 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.6 | 2.4 | GO:1990405 | protein antigen binding(GO:1990405) |
0.6 | 1.8 | GO:0031419 | cobalamin binding(GO:0031419) |
0.6 | 4.8 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.6 | 2.4 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.6 | 4.2 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.6 | 5.4 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.6 | 1.2 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.6 | 22.8 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.6 | 1.2 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.6 | 3.0 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.6 | 0.6 | GO:0032190 | acrosin binding(GO:0032190) |
0.6 | 5.3 | GO:0003796 | lysozyme activity(GO:0003796) |
0.6 | 2.4 | GO:0045182 | translation regulator activity(GO:0045182) |
0.6 | 2.9 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.6 | 0.6 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.6 | 1.2 | GO:0000339 | RNA cap binding(GO:0000339) |
0.6 | 2.3 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.6 | 5.2 | GO:0005123 | death receptor binding(GO:0005123) |
0.6 | 1.7 | GO:0005499 | vitamin D binding(GO:0005499) |
0.6 | 1.1 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.6 | 5.2 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.6 | 1.7 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.6 | 1.7 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.6 | 2.3 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.6 | 0.6 | GO:0051373 | FATZ binding(GO:0051373) |
0.6 | 1.7 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
0.6 | 44.1 | GO:0019902 | phosphatase binding(GO:0019902) |
0.6 | 3.9 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.6 | 5.0 | GO:0004568 | chitinase activity(GO:0004568) |
0.6 | 0.6 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.6 | 1.7 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.6 | 5.0 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.6 | 6.6 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.6 | 0.6 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.6 | 13.2 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.5 | 0.5 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.5 | 5.5 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.5 | 0.5 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.5 | 3.3 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.5 | 15.3 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.5 | 2.2 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.5 | 10.3 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.5 | 3.8 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.5 | 10.3 | GO:0043022 | ribosome binding(GO:0043022) |
0.5 | 5.4 | GO:0030371 | translation repressor activity(GO:0030371) |
0.5 | 2.2 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.5 | 1.6 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.5 | 11.9 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.5 | 2.1 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.5 | 4.2 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.5 | 2.1 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.5 | 0.5 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.5 | 16.9 | GO:0005518 | collagen binding(GO:0005518) |
0.5 | 2.6 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.5 | 13.7 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.5 | 2.1 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.5 | 37.1 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.5 | 0.5 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.5 | 0.5 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.5 | 0.5 | GO:0008142 | oxysterol binding(GO:0008142) |
0.5 | 9.3 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.5 | 2.6 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.5 | 6.7 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.5 | 35.4 | GO:0018423 | protein C-terminal leucine carboxyl O-methyltransferase activity(GO:0018423) |
0.5 | 2.1 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.5 | 8.6 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.5 | 1.5 | GO:0019002 | GMP binding(GO:0019002) |
0.5 | 3.0 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.5 | 4.0 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.5 | 5.5 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.5 | 12.4 | GO:0046332 | SMAD binding(GO:0046332) |
0.5 | 2.5 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.5 | 209.9 | GO:0005198 | structural molecule activity(GO:0005198) |
0.5 | 0.5 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.5 | 2.4 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.5 | 1.4 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.5 | 2.9 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.5 | 1.9 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.5 | 2.4 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.5 | 0.9 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.5 | 1.9 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.5 | 1.4 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.5 | 0.9 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.5 | 5.1 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.5 | 0.5 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.5 | 1.8 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.5 | 0.5 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.5 | 22.2 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.5 | 2.3 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.5 | 1.4 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.5 | 0.5 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.4 | 2.7 | GO:0050700 | CARD domain binding(GO:0050700) |
0.4 | 5.4 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.4 | 10.6 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.4 | 3.1 | GO:0008170 | N-methyltransferase activity(GO:0008170) |
0.4 | 3.5 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.4 | 2.2 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.4 | 5.6 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.4 | 11.2 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.4 | 4.7 | GO:0001614 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.4 | 2.1 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.4 | 1.7 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.4 | 3.4 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.4 | 0.8 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.4 | 0.8 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.4 | 2.1 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.4 | 0.8 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.4 | 34.3 | GO:0042393 | histone binding(GO:0042393) |
0.4 | 0.8 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.4 | 1.2 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.4 | 1.6 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.4 | 3.3 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.4 | 1.6 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.4 | 3.7 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.4 | 0.8 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.4 | 0.8 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.4 | 13.1 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.4 | 3.7 | GO:0001618 | virus receptor activity(GO:0001618) |
0.4 | 2.0 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.4 | 1.2 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.4 | 0.4 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.4 | 0.8 | GO:0019213 | deacetylase activity(GO:0019213) |
0.4 | 9.9 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.4 | 2.4 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.4 | 2.0 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.4 | 2.7 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.4 | 62.7 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.4 | 4.7 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.4 | 4.7 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.4 | 1.9 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.4 | 1.9 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.4 | 1.2 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.4 | 1.2 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.4 | 2.3 | GO:0048038 | quinone binding(GO:0048038) |
0.4 | 0.4 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
0.4 | 9.1 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.4 | 0.8 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.4 | 11.5 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.4 | 7.4 | GO:0016419 | S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) |
0.4 | 0.7 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.4 | 0.7 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.4 | 1.5 | GO:0043515 | kinetochore binding(GO:0043515) |
0.4 | 0.7 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.4 | 11.0 | GO:0061650 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.4 | 1.1 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.4 | 43.8 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
0.4 | 0.7 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.4 | 0.4 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.4 | 7.0 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.4 | 3.5 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.4 | 2.8 | GO:0015645 | fatty acid ligase activity(GO:0015645) |
0.4 | 0.7 | GO:0034979 | NAD-dependent histone deacetylase activity(GO:0017136) histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) NAD-dependent protein deacetylase activity(GO:0034979) |
0.3 | 0.7 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.3 | 0.3 | GO:0050693 | LBD domain binding(GO:0050693) |
0.3 | 1.4 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.3 | 1.4 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.3 | 0.3 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
0.3 | 3.3 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.3 | 17.4 | GO:0001047 | core promoter binding(GO:0001047) |
0.3 | 17.3 | GO:0004497 | monooxygenase activity(GO:0004497) |
0.3 | 4.3 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.3 | 8.9 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.3 | 1.0 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.3 | 3.0 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.3 | 2.0 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.3 | 0.3 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
0.3 | 3.2 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.3 | 1.6 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.3 | 1.0 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.3 | 0.3 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.3 | 0.6 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.3 | 0.6 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.3 | 16.0 | GO:0061659 | ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
0.3 | 0.9 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.3 | 4.4 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.3 | 0.3 | GO:0070840 | dynein complex binding(GO:0070840) |
0.3 | 0.9 | GO:0002046 | opsin binding(GO:0002046) |
0.3 | 11.5 | GO:0003823 | antigen binding(GO:0003823) |
0.3 | 1.5 | GO:0016409 | palmitoyltransferase activity(GO:0016409) |
0.3 | 0.3 | GO:0008061 | chitin binding(GO:0008061) |
0.3 | 33.4 | GO:0005125 | cytokine activity(GO:0005125) |
0.3 | 9.8 | GO:0004702 | receptor signaling protein serine/threonine kinase activity(GO:0004702) |
0.3 | 0.9 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.3 | 4.3 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.3 | 1.2 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.3 | 1.7 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.3 | 0.3 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.3 | 2.3 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.3 | 4.0 | GO:0005537 | mannose binding(GO:0005537) |
0.3 | 1.1 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.3 | 46.1 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.3 | 4.9 | GO:0008106 | alcohol dehydrogenase (NADP+) activity(GO:0008106) |
0.3 | 0.8 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.3 | 0.8 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.3 | 56.2 | GO:0003779 | actin binding(GO:0003779) |
0.3 | 0.8 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.3 | 18.8 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.3 | 3.2 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.3 | 5.3 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.3 | 0.5 | GO:0018555 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.3 | 0.3 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.3 | 8.1 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.3 | 0.5 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.3 | 2.3 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.3 | 1.3 | GO:0039706 | co-receptor binding(GO:0039706) |
0.3 | 40.1 | GO:0008134 | transcription factor binding(GO:0008134) |
0.3 | 1.3 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.2 | 3.2 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.2 | 0.2 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.2 | 0.2 | GO:0050664 | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
0.2 | 0.5 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.2 | 1.0 | GO:0035198 | miRNA binding(GO:0035198) |
0.2 | 1.0 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.2 | 0.7 | GO:0034584 | piRNA binding(GO:0034584) |
0.2 | 1.2 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.2 | 0.2 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.2 | 5.2 | GO:0015485 | cholesterol binding(GO:0015485) |
0.2 | 0.5 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.2 | 1.6 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.2 | 0.7 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.2 | 20.3 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.2 | 2.3 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.2 | 0.7 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.2 | 9.7 | GO:0019003 | GDP binding(GO:0019003) |
0.2 | 2.0 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.2 | 4.7 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
0.2 | 0.9 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.2 | 2.3 | GO:0004601 | peroxidase activity(GO:0004601) |
0.2 | 2.3 | GO:0030515 | snoRNA binding(GO:0030515) |
0.2 | 1.1 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.2 | 0.4 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.2 | 0.6 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.2 | 3.1 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.2 | 0.2 | GO:0071617 | lysophospholipid acyltransferase activity(GO:0071617) |
0.2 | 0.4 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.2 | 0.6 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.2 | 3.5 | GO:0034061 | DNA polymerase activity(GO:0034061) |
0.2 | 0.4 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.2 | 0.2 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.2 | 19.9 | GO:0003682 | chromatin binding(GO:0003682) |
0.2 | 1.7 | GO:0009975 | cyclase activity(GO:0009975) phosphorus-oxygen lyase activity(GO:0016849) |
0.2 | 7.0 | GO:0008527 | taste receptor activity(GO:0008527) |
0.2 | 0.5 | GO:0016229 | steroid dehydrogenase activity(GO:0016229) |
0.2 | 1.1 | GO:0019841 | retinol binding(GO:0019841) |
0.2 | 82.2 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.2 | 1.4 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
0.2 | 2.3 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.2 | 6.2 | GO:0008565 | protein transporter activity(GO:0008565) |
0.2 | 0.9 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.2 | 1.0 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.2 | 17.9 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.2 | 0.6 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.2 | 16.1 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.2 | 0.9 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.2 | 2.8 | GO:0051287 | NAD binding(GO:0051287) |
0.2 | 2.3 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.2 | 2.9 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 24.7 | GO:0005525 | GTP binding(GO:0005525) |
0.1 | 0.5 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.1 | 0.3 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.1 | 0.1 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.1 | 0.3 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
0.1 | 0.8 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.1 | 0.5 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.1 | 0.2 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.1 | 1.5 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.1 | 2.0 | GO:0005506 | iron ion binding(GO:0005506) |
0.1 | 0.1 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.1 | 0.2 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.1 | 0.9 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.1 | 0.2 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.1 | 0.6 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 0.3 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.1 | 0.1 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.1 | 5.7 | GO:0005179 | hormone activity(GO:0005179) |
0.1 | 1.7 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.1 | 0.3 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.1 | 1.5 | GO:0051117 | ATPase binding(GO:0051117) |
0.1 | 62.5 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.1 | 0.2 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.0 | 4.3 | GO:0005550 | pheromone binding(GO:0005550) |
0.0 | 0.3 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.0 | 0.1 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.0 | 2.2 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.0 | 1.0 | GO:0005319 | lipid transporter activity(GO:0005319) |
0.0 | 0.1 | GO:0016415 | octanoyltransferase activity(GO:0016415) |
0.0 | 0.2 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.0 | 0.3 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.0 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.0 | 0.1 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.0 | 0.5 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 0.1 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.0 | 0.4 | GO:0005186 | pheromone activity(GO:0005186) |
0.0 | 0.9 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.0 | 0.1 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.0 | 0.0 | GO:0031013 | troponin I binding(GO:0031013) |
0.0 | 0.1 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.0 | 0.1 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.0 | 0.0 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.0 | 0.3 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 0.1 | GO:0015932 | nucleobase-containing compound transmembrane transporter activity(GO:0015932) |
0.0 | 0.3 | GO:0004518 | nuclease activity(GO:0004518) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.1 | 6.1 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
3.0 | 3.0 | PID S1P S1P2 PATHWAY | S1P2 pathway |
2.8 | 44.0 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
2.7 | 27.4 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
2.7 | 37.2 | PID IL5 PATHWAY | IL5-mediated signaling events |
2.3 | 25.3 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
2.3 | 68.2 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
2.3 | 138.1 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
2.3 | 65.5 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
2.2 | 48.1 | PID EPO PATHWAY | EPO signaling pathway |
2.1 | 42.2 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
2.0 | 75.4 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
2.0 | 8.1 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
2.0 | 20.3 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
2.0 | 25.8 | PID IGF1 PATHWAY | IGF1 pathway |
1.9 | 73.3 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
1.9 | 11.4 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
1.9 | 1.9 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
1.9 | 27.8 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
1.8 | 12.7 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
1.8 | 14.2 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
1.8 | 37.2 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
1.7 | 19.1 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
1.7 | 1.7 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
1.7 | 15.1 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
1.6 | 12.4 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
1.6 | 17.1 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
1.5 | 51.1 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
1.5 | 9.3 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
1.5 | 3.1 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
1.5 | 66.5 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
1.5 | 20.5 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
1.4 | 7.2 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
1.4 | 36.1 | PID RHOA PATHWAY | RhoA signaling pathway |
1.4 | 4.3 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
1.4 | 54.9 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
1.4 | 14.0 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
1.4 | 16.7 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
1.3 | 47.1 | PID ILK PATHWAY | Integrin-linked kinase signaling |
1.3 | 13.0 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
1.3 | 10.2 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
1.3 | 5.0 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
1.2 | 25.0 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
1.2 | 17.3 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
1.2 | 9.7 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
1.2 | 15.7 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
1.2 | 59.0 | PID P73PATHWAY | p73 transcription factor network |
1.2 | 38.2 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
1.2 | 33.8 | PID RAC1 PATHWAY | RAC1 signaling pathway |
1.2 | 40.7 | PID P53 REGULATION PATHWAY | p53 pathway |
1.1 | 18.4 | PID AURORA A PATHWAY | Aurora A signaling |
1.1 | 42.1 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
1.1 | 24.3 | PID RAS PATHWAY | Regulation of Ras family activation |
1.1 | 7.7 | PID CD40 PATHWAY | CD40/CD40L signaling |
1.1 | 13.2 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
1.1 | 7.7 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
1.1 | 14.2 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
1.1 | 9.7 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
1.0 | 15.5 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
1.0 | 11.4 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
1.0 | 4.1 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
1.0 | 2.1 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
1.0 | 3.1 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
1.0 | 16.3 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
1.0 | 3.0 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
1.0 | 3.0 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
1.0 | 8.0 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
1.0 | 20.0 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
1.0 | 24.8 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
1.0 | 25.6 | PID AP1 PATHWAY | AP-1 transcription factor network |
1.0 | 43.8 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
1.0 | 12.5 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.9 | 4.7 | PID MYC PATHWAY | C-MYC pathway |
0.9 | 1.9 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.9 | 13.9 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.9 | 8.1 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.9 | 4.4 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.9 | 4.3 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.9 | 13.7 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.8 | 10.2 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.8 | 22.9 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.8 | 7.5 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.8 | 0.8 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.8 | 33.0 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.8 | 1.6 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.8 | 13.8 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.8 | 22.4 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.8 | 45.6 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.8 | 7.8 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.7 | 1.5 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.7 | 4.4 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.7 | 15.3 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.7 | 17.3 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.7 | 12.6 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.7 | 7.7 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.7 | 16.5 | NABA COLLAGENS | Genes encoding collagen proteins |
0.7 | 6.8 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.7 | 7.4 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.7 | 10.6 | PID BCR 5PATHWAY | BCR signaling pathway |
0.6 | 5.7 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.6 | 1.9 | PID IFNG PATHWAY | IFN-gamma pathway |
0.6 | 1.8 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.6 | 12.8 | PID AURORA B PATHWAY | Aurora B signaling |
0.6 | 2.4 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.6 | 3.0 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.6 | 12.8 | PID PLK1 PATHWAY | PLK1 signaling events |
0.6 | 0.6 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.6 | 4.0 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.6 | 0.6 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.6 | 6.3 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.6 | 1.7 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.6 | 6.2 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.6 | 15.5 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.6 | 0.6 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.6 | 5.0 | PID ALK2 PATHWAY | ALK2 signaling events |
0.6 | 2.8 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.5 | 4.7 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.5 | 5.7 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.5 | 1.5 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.5 | 8.8 | PID ARF6 PATHWAY | Arf6 signaling events |
0.5 | 8.2 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.5 | 10.1 | PID E2F PATHWAY | E2F transcription factor network |
0.5 | 11.0 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.5 | 0.9 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.5 | 12.6 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.5 | 1.9 | PID BARD1 PATHWAY | BARD1 signaling events |
0.4 | 4.3 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.4 | 8.6 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.4 | 4.3 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.4 | 78.9 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.4 | 5.4 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.4 | 0.8 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.4 | 3.2 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.4 | 0.8 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.4 | 1.2 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.4 | 0.4 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.4 | 3.9 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.4 | 51.7 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.4 | 46.7 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.4 | 2.5 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.4 | 5.7 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.4 | 1.4 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.3 | 2.0 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.3 | 0.7 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.3 | 1.7 | PID ENDOTHELIN PATHWAY | Endothelins |
0.3 | 0.6 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.3 | 1.8 | PID ATM PATHWAY | ATM pathway |
0.3 | 4.5 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.3 | 5.6 | PID NOTCH PATHWAY | Notch signaling pathway |
0.2 | 1.0 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.2 | 0.5 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.2 | 1.1 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.2 | 2.5 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.2 | 1.2 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.2 | 6.0 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.1 | 1.2 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 0.3 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.1 | 0.1 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 1.5 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 2.7 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.1 | 19.7 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 0.4 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 0.2 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 0.1 | PID ALK1 PATHWAY | ALK1 signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.3 | 16.4 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
3.2 | 29.0 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
3.2 | 50.6 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
3.0 | 17.8 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
3.0 | 53.1 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
2.7 | 43.7 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
2.7 | 27.2 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
2.7 | 26.9 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
2.7 | 29.5 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
2.5 | 7.4 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
2.4 | 38.8 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
2.4 | 24.2 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
2.4 | 37.9 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
2.4 | 23.6 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
2.3 | 21.0 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
2.3 | 2.3 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
2.3 | 2.3 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
2.3 | 24.8 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
2.2 | 44.2 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
2.2 | 19.6 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
2.2 | 6.5 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
2.1 | 48.7 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
2.0 | 16.4 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
2.0 | 2.0 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
1.9 | 21.4 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
1.9 | 3.8 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
1.9 | 21.2 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
1.8 | 3.6 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
1.8 | 43.7 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
1.8 | 3.5 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
1.8 | 17.7 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
1.8 | 21.1 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
1.7 | 43.7 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
1.7 | 10.5 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
1.7 | 17.3 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
1.7 | 6.9 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
1.7 | 48.2 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
1.7 | 3.4 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
1.7 | 42.0 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
1.7 | 35.1 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
1.7 | 3.3 | REACTOME SIGNALING BY FGFR | Genes involved in Signaling by FGFR |
1.7 | 36.7 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
1.7 | 15.0 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
1.6 | 7.9 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
1.6 | 20.2 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
1.5 | 18.3 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
1.5 | 23.9 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B | Genes involved in APC/C:Cdc20 mediated degradation of Cyclin B |
1.5 | 39.6 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
1.4 | 28.8 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
1.4 | 114.6 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
1.4 | 79.5 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
1.4 | 58.1 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
1.4 | 9.9 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
1.4 | 14.0 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
1.4 | 52.7 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
1.4 | 12.4 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
1.4 | 30.3 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
1.4 | 8.2 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
1.4 | 31.4 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
1.4 | 5.4 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
1.3 | 12.1 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
1.3 | 13.4 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
1.3 | 1.3 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
1.3 | 8.9 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
1.3 | 1.3 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
1.3 | 1.3 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
1.3 | 2.5 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
1.3 | 2.5 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
1.3 | 13.8 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
1.3 | 15.0 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
1.3 | 8.8 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
1.2 | 7.5 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
1.2 | 2.4 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
1.2 | 12.0 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
1.2 | 4.8 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
1.2 | 31.4 | REACTOME MEIOSIS | Genes involved in Meiosis |
1.2 | 17.3 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
1.1 | 12.6 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
1.1 | 31.6 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
1.1 | 11.3 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
1.1 | 22.3 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
1.1 | 22.0 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
1.1 | 5.5 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
1.1 | 6.5 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
1.1 | 2.2 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
1.1 | 14.0 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
1.1 | 18.1 | REACTOME G1 PHASE | Genes involved in G1 Phase |
1.1 | 15.9 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
1.1 | 14.9 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
1.1 | 18.9 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
1.0 | 16.7 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
1.0 | 5.1 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
1.0 | 8.2 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
1.0 | 1.0 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
1.0 | 8.1 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
1.0 | 11.2 | REACTOME AMYLOIDS | Genes involved in Amyloids |
1.0 | 11.0 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
1.0 | 1.0 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
1.0 | 3.9 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
1.0 | 7.7 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.9 | 7.6 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.9 | 2.8 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.9 | 7.5 | REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
0.9 | 5.6 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.9 | 4.7 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.9 | 18.7 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.9 | 1.9 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.9 | 1.9 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.9 | 13.0 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.9 | 0.9 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.9 | 12.0 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.9 | 36.8 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.9 | 2.7 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.9 | 11.9 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.9 | 7.2 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.9 | 5.4 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.9 | 14.4 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.9 | 8.1 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.9 | 26.8 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.9 | 6.2 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.9 | 0.9 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.9 | 24.3 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.9 | 2.6 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.9 | 45.2 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.8 | 24.5 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.8 | 8.3 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.8 | 1.7 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.8 | 4.1 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.8 | 17.2 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.8 | 0.8 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.8 | 3.3 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.8 | 12.0 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.8 | 5.5 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.8 | 7.0 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.8 | 3.9 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.8 | 1.5 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.8 | 30.5 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.8 | 7.6 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.8 | 9.8 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.8 | 15.0 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.7 | 19.4 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.7 | 14.1 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.7 | 2.2 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.7 | 12.3 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.7 | 6.5 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.7 | 5.7 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.7 | 5.6 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.7 | 14.0 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.7 | 34.9 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.7 | 28.6 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.7 | 2.1 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.7 | 62.5 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.7 | 7.6 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.7 | 2.8 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.7 | 2.1 | REACTOME METABOLISM OF RNA | Genes involved in Metabolism of RNA |
0.7 | 23.9 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.7 | 5.4 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.7 | 6.0 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.7 | 21.9 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.6 | 7.1 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
0.6 | 1.9 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.6 | 3.8 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.6 | 35.5 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.6 | 0.6 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.6 | 0.6 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.6 | 9.7 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.6 | 3.0 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.6 | 3.0 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.6 | 4.8 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.6 | 6.0 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.6 | 4.8 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.6 | 0.6 | REACTOME BILE ACID AND BILE SALT METABOLISM | Genes involved in Bile acid and bile salt metabolism |
0.6 | 7.4 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.6 | 3.4 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.6 | 14.6 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.6 | 6.1 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.6 | 12.2 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.6 | 9.4 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.5 | 10.4 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.5 | 23.3 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.5 | 11.9 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.5 | 1.6 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.5 | 22.3 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.5 | 2.6 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.5 | 11.1 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.5 | 18.4 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.5 | 0.5 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.5 | 4.6 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.5 | 17.2 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.5 | 0.5 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.5 | 4.5 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.5 | 4.0 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.5 | 4.9 | REACTOME LAGGING STRAND SYNTHESIS | Genes involved in Lagging Strand Synthesis |
0.5 | 1.4 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.5 | 28.4 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.5 | 7.2 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.5 | 2.3 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.5 | 39.7 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.5 | 1.8 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.5 | 2.7 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.4 | 0.9 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.4 | 4.9 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.4 | 2.6 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.4 | 3.7 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.4 | 1.2 | REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA | Genes involved in Processing of Capped Intronless Pre-mRNA |
0.4 | 5.7 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.4 | 7.2 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.4 | 3.8 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.4 | 4.5 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.4 | 15.3 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.4 | 6.7 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.4 | 0.7 | REACTOME CD28 CO STIMULATION | Genes involved in CD28 co-stimulation |
0.4 | 5.9 | REACTOME CHROMOSOME MAINTENANCE | Genes involved in Chromosome Maintenance |
0.4 | 4.2 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.3 | 7.9 | REACTOME PI3K CASCADE | Genes involved in PI3K Cascade |
0.3 | 0.6 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.3 | 2.2 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.3 | 0.6 | REACTOME TRANSCRIPTION COUPLED NER TC NER | Genes involved in Transcription-coupled NER (TC-NER) |
0.3 | 3.7 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.3 | 8.8 | REACTOME TRANSLATION | Genes involved in Translation |
0.3 | 6.5 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.3 | 3.2 | REACTOME SIGNALING BY ERBB4 | Genes involved in Signaling by ERBB4 |
0.3 | 1.8 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.3 | 2.8 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.2 | 2.9 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.2 | 1.4 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.2 | 3.8 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.2 | 4.0 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.2 | 0.6 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.2 | 6.7 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.2 | 0.2 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.2 | 1.3 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.2 | 4.2 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.2 | 4.9 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.2 | 1.1 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.2 | 0.3 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.1 | 2.2 | REACTOME DNA REPLICATION | Genes involved in DNA Replication |
0.1 | 1.7 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.1 | 0.4 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.1 | 0.8 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.1 | 18.4 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.1 | 1.1 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.1 | 0.8 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 0.9 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.1 | 2.4 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
0.1 | 0.9 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.1 | 0.1 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.1 | 3.4 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 0.2 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.1 | 0.8 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 0.3 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.1 | 0.8 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.1 | 0.2 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 0.7 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 0.1 | REACTOME TRIF MEDIATED TLR3 SIGNALING | Genes involved in TRIF mediated TLR3 signaling |
0.0 | 0.2 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.0 | 0.6 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.0 | 0.2 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |